SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT Proxy Statement Pursuant to Section 14(a) of the Securities
(Rule 14a-101)
SCHEDULE 14A INFORMATION
Exchange Act of 1934 (Amendment No. 1)
Filed by the Registrant x |
Filed by a Party other than the Registrant o | |
Check the appropriate box: | |
o | Preliminary Proxy Statement |
o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
x | Definitive Proxy Statement |
o | Definitive Additional Materials |
o | Soliciting Material Under Rule 14a-12 |
MARVELL TECHNOLOGY GROUP LTD.
N/A
Payment of Filing Fee (Check the appropriate box):
x No fee required. |
o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) Title of each class of securities to which transaction applies: |
(2) Aggregate number of securities to which transaction applies: |
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
(4) Proposed maximum aggregate value of transaction: |
(5) Total fee paid: |
o Fee paid previously with preliminary materials. |
o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. |
(1) Amount previously paid: |
(2) Form, Schedule or Registration Statement no.: |
(3) Filing Party: |
(4) Date Filed: |
MARVELL TECHNOLOGY GROUP LTD.
May 23, 2003
Dear Shareholder:
You are cordially invited to attend the 2003 Annual General Meeting of Shareholders of Marvell Technology Group Ltd., a Bermuda corporation, scheduled to be held at the offices of the Companys subsidiary, Marvell Semiconductor, Inc., 700 First Avenue, Sunnyvale, California 94089, on Friday, June 27, 2003 at 3:00 p.m. local time.
As described in the accompanying Notice of Annual General Meeting of Shareholders and Proxy Statement, shareholders will be asked to vote on the election of Class 3 directors for the Company, to appoint PricewaterhouseCoopers LLP as the Companys independent auditors for the Companys 2004 fiscal year, to authorize the Board of Directors to fix the auditors remuneration, to approve an amendment to the Companys 2000 Employee Stock Purchase Plan and to approve the Companys amended and restated 1995 Stock Option Plan. Directors and executive officers of the Company will be present at the Annual General Meeting to respond to any questions that our shareholders may have regarding the business to be transacted.
Your vote is very important, regardless of the number of shares you own. I urge you to vote your proxy as soon as possible. Whether or not you plan to attend the Annual General Meeting in person, I urge you to sign, date and promptly return the enclosed proxy card in the accompanying postage prepaid envelope. You may, of course, attend the Annual General Meeting and vote in person even if you have previously returned your proxy card.
On behalf of the Board of Directors and all of the employees of the Company, I wish to thank you for your continued support of the Company.
Sincerely yours, |
Dr. Sehat Sutardja, Ph.D. | |
Co-Chairman of the Board, President and Chief Executive Officer |
MARVELL TECHNOLOGY GROUP LTD.
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
The 2003 Annual General Meeting of Shareholders of Marvell Technology Group Ltd., a Bermuda corporation, will be held at the offices of the Companys subsidiary, Marvell Semiconductor, Inc., 700 First Avenue, Sunnyvale, California 94089, on Friday, June 27, 2003 at 3:00 p.m. local time, subject to adjournment or postponement by the Board of Directors, for the following purposes:
1. | To elect three directors constituting Class 3 of the Companys Board of Directors, each to hold office for a three-year term and until his or her successor is duly elected and qualified; | |
2. | To re-appoint PricewaterhouseCoopers LLP as the independent auditors of the Company for the Companys 2004 fiscal year ending January 31, 2004 and to authorize the Board of Directors to fix the auditors remuneration; | |
3. | To approve an amendment to the Companys 2000 Employee Stock Purchase Plan; | |
4. | To approve the Companys amended and restated 1995 Stock Option Plan; and | |
5. | To transact such other business as may properly come before the Annual General Meeting or any or all adjournments or postponements thereof. |
The Company will also lay before the meeting the financial statements of the Company for the fiscal year ended February 1, 2003 pursuant to the provisions of the Bermuda Companies Act of 1981 and the Companys Bye-Laws.
Only holders of record of common stock of the Company on May 2, 2003, will be entitled to notice of, and to vote at, the Annual General Meeting and any adjournment or postponement thereof.
In order to constitute a quorum for the conduct of business at the Annual General Meeting, it is necessary that holders of a majority of all outstanding shares of common stock be present in person or be represented by proxy. Your attention is invited to the accompanying proxy statement. To assure your representation at the Annual General Meeting, please date, sign and mail the enclosed proxy, for which a return envelope is provided. Execution of a proxy will not in any way affect a shareholders right to attend the Annual General Meeting and vote in person, and any person giving a proxy has the right to revoke it at any time before it is exercised.
By order of the Board of Directors | |
WEILI DAI | |
Secretary |
PLEASE SIGN, DATE AND RETURN THE ENCLOSED PROXY CARD PROMPTLY.
TABLE OF CONTENTS
Page | ||||
Notice of Annual General Meeting of Shareholders
|
||||
Proxy Statement
|
1 | |||
Proposal No. 1 Election of Directors
|
4 | |||
Proposal No. 2 Re-Appointment of Independent
Auditors
|
8 | |||
Proposal No. 3 Approval of Amendment to the
2000 Employee Stock Purchase Plan
|
9 | |||
Proposal No. 4 Approval of Amended and
Restated 1995 Stock Option Plan
|
12 | |||
Security Ownership of Certain Beneficial Owners
and Management
|
17 | |||
Board of Directors and Committees of the Board
|
20 | |||
Compensation Committee Interlocks and Insider
Participation
|
21 | |||
Executive Compensation
|
22 | |||
Option Grants in Last Fiscal Year
|
23 | |||
Option Exercises in Last Fiscal Year and Fiscal
Year-End Option Values
|
24 | |||
Joint Report of the Compensation and Stock Option
Committees
|
25 | |||
Report of the Audit Committee
|
27 | |||
Information Concerning Independent Auditors
|
28 | |||
Stock Price Performance Graph
|
29 | |||
Related Party Transactions
|
30 | |||
Shareholder Proposals For the 2004 Annual General
Meeting
|
30 | |||
Other Matters
|
31 | |||
Section 16(a) Beneficial Ownership Reporting
Compliance
|
31 | |||
Annual Report on Form 10-K
|
32 |
i
MARVELL TECHNOLOGY GROUP LTD.
INTRODUCTION
This proxy statement is furnished in connection with the solicitation by the Board of Directors of Marvell Technology Group Ltd., a Bermuda corporation (Marvell or the Company), of proxies for use at the 2003 Annual General Meeting of Shareholders of the Company scheduled to be held at the offices of the Companys subsidiary, Marvell Semiconductor, Inc., 700 First Avenue, Sunnyvale, California 94089, on Friday, June 27, 2003 at 3:00 p.m. local time, and at any and all postponements and adjournments thereof.
INFORMATION REGARDING VOTING AT THE ANNUAL GENERAL MEETING
General
At the Annual General Meeting, the shareholders of the Company are being asked to consider and to vote upon (1) the election of the three directors constituting Class 3 of the Board of Directors nominated by the Companys Board of Directors to serve until the Annual General Meeting of Shareholders to be held in calendar year 2006 (see Election of Directors at page 4 of this proxy statement); (2) the appointment of PricewaterhouseCoopers LLP as the Companys independent auditors for its 2004 fiscal year and to authorize the Board of Directors to fix the auditors remuneration (see Re-Appointment of Independent Auditors at page 8 of this proxy statement); (3) the approval of an amendment to the Companys 2000 Employee Stock Purchase Plan (see Approval of Amendment to 2000 Employee Stock Purchase Plan at page 9 of this proxy statement); and (4) the approval of the Companys amended and restated 1995 Stock Option Plan (see Approval of Amended and Restated 1995 Stock Option Plan at page 12 of this proxy statement). Shares represented by properly executed proxies received by the Company will be voted at the Annual General Meeting in the manner specified therein or, if no instructions are marked on the proxy card, FOR each of the director nominees identified on such card, FOR the appointment of PricewaterhouseCoopers LLP as the Companys independent auditors for the Companys 2004 fiscal year and to authorize the Board of Directors to fix the auditors remuneration, FOR approval of the amendment to the Companys 2000 Employee Stock Purchase Plan and FOR approval of the Companys amended and restated 1995 Stock Option Plan. Although management does not know of any other matter to be acted upon at the Annual General Meeting, unless contrary instructions are given, shares represented by valid proxies will be voted by the persons named on the accompanying proxy card in accordance with their respective best judgment with respect to any other matters that may properly come before the Annual General Meeting.
The approximate date on which this proxy statement and the enclosed proxy card are first being sent to shareholders is May 23, 2003.
Principal Executive Office
The mailing address of the principal executive offices of the Company is 4th Floor, Windsor Place, 22 Queen Street, P.O. Box HM 1179, Hamilton HM EX, Bermuda, and our telephone number there is (441) 296-6395.
Record Date and Voting
May 2, 2003 has been set as the record date for the Annual General Meeting. Only shareholders of record on Friday, May 2, 2003, will be entitled to notice of and to vote at the Annual General Meeting. On the record date, 122,039,100 shares of the Companys common stock, par value $0.002 per share (the Common Stock), were outstanding. Each share of outstanding common stock is entitled to one vote on each matter to be voted on at the Annual General Meeting.
The presence, in person or by proxy, of the holders of at least a majority of the voting power of the stock issued and outstanding and entitled to vote is necessary to constitute a quorum at the Annual General Meeting. In the event there are not sufficient votes for a quorum at the time of the Annual General Meeting, the Annual General Meeting may be adjourned in order to permit the further solicitation of proxies.
Abstentions and broker non-votes are counted for the purpose of determining the presence or absence of a quorum for the transaction of business. With regard to the election of directors, votes may be cast in favor or withheld. Directors are elected by plurality, and therefore votes that are withheld and broker non-votes will be excluded entirely from the vote and will have no effect. Abstentions are counted in tabulations of the votes cast on proposals presented to shareholders other than the election of directors, thus having the effect of a negative vote, whereas broker non-votes are not counted for purposes of determining whether a proposal has been approved and therefore will have no effect on the outcome of such matter, subject to limited exceptions. Any shareholder proposals that properly come before the Annual General Meeting require, in general, the affirmative vote of a majority of the voting power of the shares of common stock present, in person or represented by proxy, at the Annual General Meeting and entitled to vote on the subject matter.
Shareholders should complete and return the proxy card as soon as possible. To be valid, the proxy card must be completed in accordance with the instructions on it and received at the address set forth below by 2:00 p.m., local time, on June 27, 2003:
Marvell Technology Group Ltd. c/o Wachovia Bank Attn: Proxy Tabulation NC-1153 P.O. Box 217950 Charlotte, NC 28254-3555 U.S.A. |
No postage is required if the proxy is mailed in the enclosed envelope within the United States to the United States address set forth above.
Revocation of Proxies
Execution of a proxy will not in any way affect a shareholders right to attend the Annual General Meeting and vote in person, and any person giving a proxy has the right to revoke it at any time before it is exercised. A proxy may be revoked by either:
| delivering to the Secretary of the Company, prior to the commencement of the Annual General Meeting, either a written notice of revocation or a duly executed proxy bearing a later date at the address set forth above; or | |
| voting in person at the Annual General Meeting. |
Solicitation
The Company is making this solicitation, and the cost of preparing, assembling and mailing the Notice of Annual General Meeting of Shareholders, this Proxy Statement and the enclosed proxy card will be paid by the Company. Following the mailing of this proxy statement, directors, officers and other employees of the Company may solicit proxies by mail, telephone, e-mail or in person. These persons will receive no additional compensation for these services. Brokerage houses and other nominees, fiduciaries and custodians nominally holding shares of common stock of record will be requested to forward proxy soliciting material to the
2
PRESENTATION OF FINANCIAL STATEMENTS
In accordance with Section 84 of the Companies Act 1981 of Bermuda and Bye-Law 73 of the Company, the Companys audited consolidated financial statements for the fiscal year ended February 1, 2003 will be presented at the Annual General Meeting. These statements have been approved by the Companys directors. There is no requirement under Bermuda law that these statements be approved by shareholders, and no such approval will be sought at the meeting.
3
Proposal No. 1
ELECTION OF DIRECTORS
The number of directors of the Company is currently nine. The Board of Directors is divided into three classes with each class having three members. One class of the Board of Directors is elected each year. At the Annual General Meeting, shareholders of the Company will be asked to vote on the election of three directors as Class 3 directors. All directors elected at the Annual General Meeting will be elected to three-year terms and will serve until their successors have been duly elected and qualified.
Nominees for Election
Set forth below is the names of the persons nominated by the Companys Board of Directors for election as Class 3 directors at the Annual General Meeting. The information set forth below as to the nominees has been furnished by the nominees.
Class of | Term | ||||||||||||||||
Name | Age | Director | Expires | Background | |||||||||||||
Dr. Sehat Sutardja,
|
|||||||||||||||||
Ph.D.(1)
|
41 | 3 | 2006 | Dr. Sehat Sutardja, one of our co-founders, has served as President of Marvell Technology Group, Ltd. since its inception and as our Co-Chairman of the Board and Chief Executive Officer since 1995. In addition, he has served as President, Chief Executive Officer and a director of Marvell Semiconductor, Inc. since its inception. From 1989 until 1995, Dr. Sutardja served as a manager and principal project engineer at 8x8, Inc., a designer and manufacturer of digital communications products. Dr. Sutardja holds Master of Science and Ph.D. degrees in Electrical Engineering and Computer Science from the University of California at Berkeley. Dr. Sutardja is the husband of Weili Dai and the brother of Dr. Pantas Sutardja. | |||||||||||||
Weili Dai(1)
|
41 | 3 | 2006 | Weili Dai, one of our co-founders, has served as Vice President, Corporate Secretary and a director of Marvell Technology Group, Ltd. since its inception in 1995. Since 1999, Ms. Dai has served as Executive Vice President and General Manager of the Communications Business Group. In this role, she is responsible for managing all of the Companys communications product lines. Ms. Dai has also served as Executive Vice President and a Director of Marvell Semiconductor, Inc. since its inception. From 1992 until 1995, Ms. Dai was involved in software development and project management at Canon Research Center America, Inc. Ms. Dai holds a Bachelor of Science degree in Computer Science from the University of California at Berkeley. Ms. Dai is the wife of Dr. Sehat Sutardja. |
4
Class of | Term | ||||||||||||||||
Name | Age | Director | Expires | Background | |||||||||||||
Dr. Pantas Sutardja,
|
|||||||||||||||||
Ph.D.
|
40 | 3 | 2006 | Dr. Pantas Sutardja, one of our co-founders, has served as Vice President and a director of Marvell Technology Group, Ltd. since its inception in 1995, and as Vice President of Engineering for Marvell Semiconductor, Inc. from its inception until 1999, when he was appointed Chief Technology Officer. Dr. Pantas Sutardja has also been a director of Marvell Semiconductor, Inc. since its inception. Dr. Pantas Sutardja holds Bachelor of Science, Master of Science and Ph.D. degrees in Electrical Engineering and Computer Science from the University of California at Berkeley. Dr. Pantas Sutardja is the brother of Dr. Sehat Sutardja. |
(1) | Member of Stock Option Committee |
The Company has been advised by each nominee named in this proxy statement that he or she is willing to be named as such herein and is willing to serve as a director if elected. However, if any of the nominees should be unable to serve as a director, the enclosed proxy will be voted in favor of the remainder of those nominees not opposed by the shareholder on such proxy and may be voted for a substitute nominee selected by the Board of Directors.
Board Recommendation and Required Vote
The Board of Directors recommends that you vote FOR all of the nominees for director identified above. Unless authority to do so is withheld, the proxy holders named in each proxy will vote the shares represented thereby FOR the election of all of the nominees for director named above. Assuming the presence of a quorum, directors will be elected by a plurality of the votes of the shares present and entitled to vote at the Annual General Meeting. Because directors are elected by plurality, abstentions and broker non-votes will be entirely excluded from the vote and will have no effect on the outcome.
Other Directors
The following table sets forth information with respect to the other directors of the Company. The information as to each director has been furnished by the director.
Class of | Term | |||||||||||||||
Name of Director | Age | Director | Expires | Background | ||||||||||||
Diosdado P. Banatao(2)(3)
|
56 | 2 | 2005 | Co-Chairman of the Board since October 1995. Mr. Banatao is currently the managing partner of Tallwood Venture Capital which he founded in June 2000. He was a venture partner in Mayfield Fund, a venture capital fund, from 1998 to until June 2000. Prior to joining Mayfield Fund, Mr. Banatao founded S3, Incorporated, a designer and manufacturer of graphics and video accelerators for personal computers and related peripheral products, where he served as President and Chief Executive Officer from 1989 until 1992 and Chairman from 1992 to 1998. Mr. Banatao holds a Bachelor of Science degree in Electrical Engineering from the Mapua Institute of Technology and a Master of Science degree in Electrical Engineering and Computer Science from Stanford University. |
5
Class of | Term | ||||||||||||||||
Name of Director | Age | Director | Expires | Background | |||||||||||||
Kuo Wei (Herbert)
|
|||||||||||||||||
Chang(2)(3)
|
41 | 2 | 2005 | A director since November 1996. Since April 1996, Mr. Chang has been President of InveStar Capital, Inc., a technology venture capital management firm based in Taiwan. Since February 1998, Mr. Chang has also been the managing member of Forefront Associates LLC, which is the general partner of Forefront Venture Partners, L.P. From 1994 to 1996, Mr. Chang was Senior Vice President of WK Technology Fund, a venture capital fund. Mr. Chang serves as a director for Oplink Communications, Inc. Mr. Chang holds a Bachelor of Science degree from National Taiwan University and a Master of Business Administration degree from National Chiao-Tung University in Taiwan. | |||||||||||||
Ronald D.
|
|||||||||||||||||
Verdoorn(2)
|
52 | 2 | 2005 | A director since January 1998. From January 1999 to 2002, Mr. Verdoorn served as Executive Vice President of Global Operations for Affymetrix, Inc., a company specializing in the development of technology for acquiring and managing complex genetic information for use in biomedical research, genomics and clinical diagnostics. From 1997 to 1999, Mr. Verdoorn served as an independent consultant to the hard disk drive industry. From 1983 to 1997, Mr. Verdoorn held a number of positions with Seagate Technology, Inc., most recently as Executive Vice President and Chief Operating Officer of Storage Products. Mr. Verdoorn holds a Bachelor of Arts degree in Sociology from Linfield College. | |||||||||||||
Dr. John M. Cioffi,
|
|||||||||||||||||
Ph.D.(3)
|
46 | 1 | 2004 | A director since March 2000. Mr. Cioffi has been a professor of Electrical Engineering at Stanford University since 1986. In 1991, he founded Amati Communications Corporation, which designs and manufactures modems for Asymmetric Digital Subscriber Lines, and served as the Chief Technology Officer and Vice President until the companys acquisition by Texas Instruments, Inc. in 1998. Dr. Cioffi is an IEEE fellow and serves as a director for ITEX. Dr. Cioffi holds a Bachelor of Science from the University of Illinois and Master of Science and Ph.D. degrees from Stanford University. |
6
Class of | Term | ||||||||||||||||
Name of Director | Age | Director | Expires | Background | |||||||||||||
Dr. Paul R. Gray,
|
|||||||||||||||||
Ph.D.(3)
|
60 | 1 | 2004 | A director since March 2000. Since July 2000, Dr. Gray has served as Executive Vice Chancellor and Provost at the University of California at Berkeley. During his 28-year tenure with the University, Dr. Gray has held numerous administrative posts, including Director of the Electronics Research Laboratory, Vice Chairman of the EECS Department for Computer Resources, Dean of the College of Engineering and Chairman of the Department of Electrical Engineering and Computer Sciences. Dr. Gray holds Bachelor of Science, Master of Science and Ph.D. degrees in Electrical Engineering from the University of Arizona, Tuscon. | |||||||||||||
Manuel Alba
|
47 | 1 | 2004 | A director since January 2001. Mr. Alba served as Vice President of Strategy and Business Development of the Communications Business Group of Marvell Semiconductor, Inc., from January 2001 to December 2002. From April 1994 until the acquisition of Galileo Technology Ltd. by the Company in January 2001, Mr. Alba served as a director and the President of Galileo Technology Ltd. and as President of Galileo Technology, Inc. Mr. Alba holds a Bachelor of Science degree in Electrical Engineering from the National Polytechnic Institute in Mexico City, a Master of Science degree in Electrical Engineering from the University of Southern California and a Master of Business Administration degree from the University of Santa Clara. |
(1) | Member of the Stock Option Committee. |
(2) | Member of the Audit Committee. |
(3) | Member of the Compensation Committee. |
7
Proposal No. 2
RE-APPOINTMENT OF INDEPENDENT AUDITORS
In accordance with Section 89 of the Companies Act 1981 of Bermuda, the Companys shareholders have the authority to appoint the Companys independent auditors and to authorize the Board of Directors to fix the auditors remuneration. At the meeting, shareholders will be asked to re-appoint PricewaterhouseCoopers LLP as the Companys independent auditors and to authorize the Board of Directors to fix their remuneration.
Board Recommendation and Required Vote
The Board of Directors recommends that you vote FOR the re-appointment of PricewaterhouseCoopers LLP as the Companys independent auditors for the 2004 fiscal year and to authorize the Board of Directors to fix the remuneration of PricewaterhouseCoopers LLP. The affirmative vote of the holders of Common Stock representing a majority of the voting power of the outstanding Common Stock, present or represented by proxy and voting at the Annual General Meeting, is required to appoint PricewaterhouseCoopers LLP and to authorize the Board of Directors to fix their remuneration. In the event that the shareholders do not appoint independent auditors at the Annual General Meeting, the Board of Directors is required under Bermuda law to forthwith appoint independent auditors and will do so.
8
Proposal No. 3
APPROVAL OF AMENDMENT TO THE 2000 EMPLOYEE STOCK PURCHASE PLAN
The Companys 2000 Employee Stock Purchase Plan (the Purchase Plan) was adopted by the Board of Directors in June 2000 and subsequently approved by the shareholders of the Company. The Purchase Plan includes an annual increase in shares reserved for issuance equal to the lesser of (a) 500,000 shares, (b) 0.75% of the outstanding shares of capital stock of the Company on such date or (c) an amount of shares determined by the Board of Directors. On May 7, 2003, the Board of Directors approved an amendment to the Purchase Plan (the Amended Purchase Plan) to provide that the annual increase in shares reserved for issuance be equal to the lesser of (a) 2,000,000 shares or (b) 1.5% of the outstanding shares of capital stock of the Company on such date, which amendment is subject to shareholder approval. The Board of Directors believes that the availability of an adequate number of shares in the share reserve of the Amended Purchase Plan is an important factor in attracting, motivating and retaining qualified officers and employees essential to the success of the Company.
The text of the Amended Purchase Plan was filed with the Securities and Exchange Commission as Appendix A to this Proxy Statement and a copy of the Amended Purchase Plan will be made available to any shareholder upon written request.
The following summary of the Amended Purchase Plan does not purport to be complete. It is subject to and qualified in its entirety by the specific language of the Amended Purchase Plan.
General
The total number of shares authorized for issuance as of January 31, 2003 is 2,000,000.
Eligibility
Any employee of the Company or any of its subsidiaries which has been designated by the Board as a participating employer under the Purchase Plan are eligible to participate in the Amended Purchase Plan as long as the employee is employed by the Company or the subsidiary prior to the offering date, is customarily employed for at least 20 hours per week and is customarily employed for at least five months each year. No employee shall be granted a right to purchase shares under the Amended Purchase Plan if, immediately after such grant, such employee would own or hold options to purchase stock of the Company or of any parent corporation or subsidiary corporation possessing 5% or more of the total combined voting power or value of all classes of stock of such corporation or if and to the extent that, his or her rights to purchase stock under all of our employee stock purchase plans accrue at a rate that exceeds $25,000 worth of stock per calendar year. As of January 31, 2003, all non-executive officers and one executive officer were eligible to participate in the Purchase Plan and continue to be eligible under the Amended Purchase Plan.
Purchase of Shares
The Amended Purchase Plan permits eligible employees to purchase shares of Common Stock through payroll withholding. Each offering period commencing under the Amended Purchase Plan is 24 months and is divided into four consecutive six-month purchase periods. At the end of each purchase period, shares are issued based on payroll deductions accumulated during that period not to exceed 20% of the employees base compensation, which will include regular straight-time gross earnings and exclude overtime, shift premiums, incentive compensation or payments, bonuses, and commissions. The purchase price per share at which the shares of the Common Stock are sold under the Amended Purchase Plan generally will be equal to 85% of the lesser of the fair market value of the Common Stock on (a) the first day of the offering period or (b) the purchase date. No participant may purchase more than 2,500 shares of the Common Stock in any offering, or shares having a fair market value exceeding $25,000 in any calendar year. A participant may withdraw from an
9
Administration
The Amended Purchase Plan is administered by the Board of Directors or a committee appointed by the Board of Directors. As of January 31, 2003, a total of 962,392 shares had been purchased under the Purchase Plan and 1,037,608 remained available for purchase. The closing market price for the Common Stock on the Nasdaq National Market on January 31, 2003 was $18.27.
Amendments
The Board of Directors may at any time amend or terminate the Amended Purchase Plan except that shareholder approval is required to increase the number of shares authorized for issuance under the Amended Purchase Plan. As in the Purchase Plan, the Amended Purchase Plan does permit the Board to designate certain affiliated corporations whose employees may participate without shareholder approval. In addition, except as required by law or regulation, no amendment to the Amended Purchase Plan may adversely affect the purchase rights previously granted a participant under the Purchase Plan or the Amended Purchase Plan without such participants consent.
Summary of Federal Income Tax Consequences of the Amended Purchase Plan
The following summary is intended only as a general guide as to the federal income tax consequences under current law of options granted pursuant to the Amended Purchase Plan and does not attempt to describe all potential tax consequences. Furthermore, the tax consequences are complex and subject to change, and a taxpayers particular situation may be such that some variation of the described rules is applicable.
A participant recognizes no taxable income either as a result of commencing participation in the Amended Purchase Plan or purchasing shares of Common Stock under the terms of the Amended Purchase Plan.
If a participant disposes of shares purchased under the Amended Purchase Plan within two years from the first day of the applicable offering period or within one year from the date of purchase (a disqualifying disposition), the participant will recognize ordinary income in the year of such disposition equal to the amount by which the fair market value of the shares on the date the shares were purchased exceeds the purchase price. The amount of ordinary income will be added to the participants basis in the shares and any additional gain or resulting loss recognized on the disposition of the shares will be a capital gain or loss. A capital gain or loss will be long-term if the participants holding period is more than 12 months, otherwise it will be short-term.
If the participant disposes of shares purchased under the Amended Purchase Plan more than two years after the first day of the applicable offering period and more than a year after the date of purchase, the participant will recognize ordinary income in the year of disposition equal to the lesser of (a) the excess of the fair market value of the shares on the date of disposition over the purchase price or (b) 15% of the fair market value of the shares on the first day of the applicable offering period. The amount of any ordinary income will be added to the participants basis in the shares and any additional gain recognized upon the disposition after such basis adjustment will be long-term capital gain. If the fair market value of the shares on the date of disposition is less than the purchase price, there will be no ordinary income and any loss recognized will be a long-term capital loss.
The Company will be entitled to a deduction in the year of a disqualifying disposition equal to the amount of ordinary income recognized by the participant as a result of the disposition. In all other cases, no deduction is allowed to the Company.
10
Board Recommendation and Required Vote
The Board of Directors recommends that you vote FOR the approval of the amendment to the Companys 2000 Employee Stock Purchase Plan. The affirmative vote of the holders of a majority of shares of Common Stock represented and voting at a duly held meeting at which a quorum is present is required to approve the amendment to the Purchase Plan. Unless marked to the contrary, proxies received will be voted FOR approval of the amendment to the Companys 2000 Employee Stock Purchase Plan.
11
Proposal No. 4
APPROVAL OF AMENDED AND RESTATED 1995 STOCK OPTION PLAN
The Companys 1995 Stock Option Plan (the 1995 Plan) was adopted by the Companys Board of Directors in April 1995 and subsequently approved by its shareholders. On May 7, 2003, the Board of Directors amended and restated the 1995 Plan, subject to approval by the shareholders, to: (a) extend the term of the 1995 Plan beyond 2005 until terminated by the Board of Directors pursuant to Section 15 of the 1995 Plan, except that no incentive stock option shall be granted on or after the 10th anniversary of the later of (x) the date the Board of Directors adopted the 1995 Plan or (y) the date when the Board of Directors adopted the most recent increase in the number of shares available under the 1995 Plan that was approved by shareholders; (b) provide for a one-time increase in the number of shares available for issuance under the 1995 Plan in an amount equal to 10,000,000 shares of Common Stock; (c) permit discretionary grants of options to new outside directors upon their initial appointment to the Board of Directors; (d) provide for additional types of stock-based awards; (e) provide for an annual increase in the number of shares available for issuance under the 1995 Plan in an amount equal to the lesser of 5% of the outstanding shares of capital stock or 10,000,000 shares of Common Stock; and (f) add provisions appropriate for a public company and delete certain provisions that were required before the Company became a public company. These changes are to be effective as of May 7, 2003.
The text of the amended and restated 1995 Plan was filed with the Securities and Exchange Commission as Appendix B to this Proxy Statement and a copy of the amended and restated 1995 Plan will be made available to any shareholder upon written request.
The following summary of the amended and restated 1995 Plan does not purport to be complete. It is subject to and qualified in its entirety by the specific language of the amended and restated 1995 Plan.
Shares Subject to the Plan
The purpose of the amended and restated 1995 Plan is to attract and retain employees, consultants and non-employee directors of the Company and its subsidiaries. The amended and restated 1995 Plan provides for awards in the form of stock options, stock appreciation rights, stock awards, stock units, performance awards and other stock-based awards (Awards). No awards other than stock options have been made under the 1995 Plan.
As of January 31, 2003, and prior to the amendment and restatement of the 1995 Plan, there were 44,197,398 shares of Common Stock authorized and reserved for issuance under the 1995 Plan. The authorized shares issuable in connection with the amended and restated 1995 Plan are subject to adjustment in the event of stock splits, stock dividends and other situations.
As of January 31, 2003, the Company had options outstanding under the 1995 Plan to purchase a total of 20,492,881 shares of Common Stock at exercise prices ranging from $0.03 to $93.88, or a weighted-average exercise price per share of $15.83. If any stock options, stock units or stock appreciation rights granted under the 1995 Plan are forfeited, or if any stock options or stock appreciation rights terminated for any other reason without being exercised in full, then the underlying shares of Common Stock will once again be available for additional awards under the amended and restated 1995 Plan. As of January 31, 2003, a total of 4,654,068 shares of Common Stock were available for future issuance under the 1995 Plan.
Participants
Employees, consultants and outside directors of the Company and its subsidiaries are eligible to participate in the amended and restated 1995 Plan, although incentive stock options may be granted only to employees of the Company or of its subsidiaries. The participation of outside directors of the Company is limited to the grant of nonstatutory stock options upon initial appointment to the Board of Directors and must be approved by the Board of Directors.
Administration
The amended and restated 1995 Plan is administered by the Board of Directors or a committee appointed by the Board of Directors. The Stock Option Committee administers the 1995 Plan with respect to employees
12
Payment
Payment for shares upon exercise of an option shall be made in any lawful consideration approved by the Board or committee appointed by the Board and may, without limitation, consist of (1) cash, (2) check, or (3) other shares that have a Fair Market Value on the date of payment equal to the aggregate exercise price of the shares as to which option is exercised.
Stock Appreciation Rights
Stock appreciation rights permit the participant to elect to receive any appreciation in the value of the underlying stock from the Company, either in shares of Common Stock or in cash or a combination of the two, with the Stock Option Committee or Compensation Committee, as applicable, having the discretion to determine the form in which such payment will be made. The amount payable on exercise of a stock appreciation right is measured by the difference between the market value of the underlying Common Stock at exercise and the exercise price.
Stock Awards
Stock awards are restricted or unrestricted awards of Common Stock on such terms and conditions and for such consideration, including no consideration or such minimum consideration as may be required by law, as the Stock Option Committee or the Compensation Committee shall determine.
Stock Units
A stock unit is an unfunded bookkeeping entry representing the equivalent of one share of Common Stock. A holder of stock units has no voting rights or other privileges as a shareholder but may be entitled to receive dividend equivalents equal the amount of any dividends paid on the same number of shares of Common Stock. Dividend equivalents may be converted into additional stock units or settled in the form of cash, Common Stock or a combination of both.
Stock units, when vested, may be settled by distributing shares of Common Stock or by a cash payment corresponding to the fair market value of the appropriate number of shares of Common Stock, or a combination of both.
Stock Options
Stock options may include nonqualified stock options as well as incentive stock options intended to qualify for special tax treatment. The term of an incentive stock option cannot exceed 10 years. The exercise price of incentive stock options may not be less than 100% of the fair market value of the Common Stock as of the date of grant (110% of the fair market value if the grant is to an employee who owns more than 10% of the total combined voting power of all classes of capital stock of the Company). The Code currently limits to $100,000 the aggregate value of Common Stock based on the date of grant value for which an incentive stock options granted under the amended and restated 1995 Plan or any other option plan adopted by the Company may first becoming exercisable in any calendar year. Nonstatutory stock options may be granted under the amended and restated 1995 Plan at an exercise price of not less than 100% of the fair market value of the Common Stock on the date of grant. Nonstatutory stock options also may be granted without regard to any restriction on the amount of Common Stock for which the option may be exercised in any one year. On January 31, 2003, the closing price for the Common Stock on the Nasdaq National Market was $18.27 per share.
13
The exercise price of an option may be paid in any lawful form permitted by the Stock Option Committee or Compensation Committee, as applicable, including, without limitation, the surrender of shares of Common Stock already owned by the optionee provided that the Company will not have an adverse change to earnings for financial reporting purposes. The Stock Option Committee or Compensation Committee, as applicable, may also permit optionees to satisfy their tax withholding obligation upon exercise of an nonqualified stock option by surrendering a portion of their option shares to the Company.
As of January 31, 2003, the following persons or groups had in total, received options to purchase shares of Common Stock under the 1995 Plan as follows: (i) the Chief Executive Officer and the other executive officers named in the Summary Compensation Table: Dr. Sehat Sutardja, Weili Dai, Dr. Pantas Sutardja and George Hervey; (ii) all current executive officers of the Company as a group: 1,310,000 shares; (iii) all current directors who are not executive officers as a group: 4,370,000 shares; and (iv) all employees of the Company, including all current officers and general managers of the Companys subsidiaries who are not executive officers and as a group: 46,028,675 shares.
Vesting Conditions
As noted above, the Stock Option Committee or Compensation Committee, as applicable, determines the number of stock appreciation rights, stock awards, stock options or stock units to be included in the award, as well as the vesting and other conditions. The vesting conditions may be based on the employees service, his or her individual performance, the Companys performance or other criteria. Vesting may be accelerated in the event of the employees death, disability or retirement, in the event of a change in control with respect to the Company or upon other events. In addition, the Stock Option Committee or Compensation Committee, as applicable, may determine that outstanding options and stock appreciation rights will become fully vested if it has concluded that a change in control has occurred.
For purposes of the amended and restated 1995 Plan, the term change in control is defined as (a) the acquisition, directly or indirectly, of at least 50% of the total combined voting power of the Companys outstanding securities pursuant to a tender or exchange offer made directly to the Companys shareholders that the Board of Directors does not recommend the shareholders accept; (b) a change in the majority of the composition of the Board of Directors over a period of 36 consecutive months if such change was not approved by a majority of the existing directors; (c) certain mergers or consolidations of the Company; (d) sale of all or substantially all of the Companys assets to any other person or entity other than a subsidiary of the Company; and (e) the liquidation or dissolution of the Company.
Transferability of Awards
Recipients of awards under the amended and restated 1995 Plan may sell, donate, pledge or otherwise transfer their awards only to the extent provided in the applicable agreement. In addition, awards, other than incentive stock options, may only be transferred to the recipients spouse, children or grandchildren; a trust established for the recipients benefit and/or the benefit of the recipients spouse, children or grandchildren; or certain family partnerships. Incentive stock options are not transferable during the optionees lifetime.
Modifications
The Stock Option Committee or Compensation Committee, as applicable, is authorized, within the provisions of the amended and restated 1995 Plan, to amend the terms of outstanding stock awards or stock units or to modify, extend or assume outstanding options or stock appreciation rights or may accept the cancellation of outstanding options or stock appreciation rights in return for the grant of new options for the same or a different number of shares and at the same or a different exercise price.
Summary of Federal Income Tax Consequences
The following discussion of the federal income tax consequences of the amended and restated 1995 Plan is intended to be a summary of applicable federal law. State and local tax consequences may differ. Because the federal income tax rules governing options and related payments are complex and subject to frequent
14
Incentive stock options and nonqualified stock options are treated differently for federal income tax purposes. Incentive stock options are intended to comply with the requirements of section 422 of the Code. Nonstatutory stock options need not comply with such requirements.
An employee is not taxed on the grant or exercise of an incentive stock option. The difference between the exercise price and the fair market value on the exercise date of the shares acquired under an incentive stock option will, however be a preference item for purposes of the alternative minimum tax. If an optionee holds the shares acquired upon exercise of an incentive stock option for a least two (2) years following grant and at least one (1) year following exercise, the optionees gain, if any, upon a subsequent disposition of such shares is long-term capital gain. The measure of the gain is the difference between the proceeds received on disposition and the optionees basis in the shares (which generally equals the exercise price).
If an optionee disposes of stock acquired upon the exercise of an incentive stock option before satisfying the one and two year holding periods described above, the optionee may recognize both ordinary income and capital gain in the year of disposition. The amount of the ordinary income will be the lesser of (a) the amount realized on disposition less the optionees adjusted basis in the stock (usually the option exercise price) or (b) the difference between the fair market value of the stock on the exercise date and the option exercise price. The balance of the consideration received on such a disposition will be capital gain (long-term capital gain if the stock had been held for at least one year after the exercise of the incentive stock option). The Company is not entitled to an income tax deduction on the grant or exercise of an incentive stock option or on the optionees disposition of the shares after satisfying the holding period requirement described above. If the holding periods are not satisfied, the Company will be entitled to a deduction in the year the optionee disposes of the shares, in an amount recognized by the optionee.
An employee is not taxed on the grant of a nonqualified stock option. On exercise, however, the optionee recognizes ordinary income equal to the difference between the option price and the fair market value of the shares on the date of exercise. The Company is entitled to an income tax deduction in the year of exercise in the amount recognized by the optionee as ordinary income. Any gain on subsequent disposition of the shares is long-term capital gain if the shares are held for at least one year after exercise. The Company does not receive a deduction for this gain.
New Plan Benefits
With respect to all future grants, the Stock Option Committee or the Compensation Committee, as applicable, has full discretion to determine the number and amount of options to be granted to employees under the 1995 Plan, subject to an annual limitation on the total number of options that may be granted to any employee, and subject to a requirement that the Board of Directors approve the grants of stock options to outside directors in connection with their initial appointment. Therefore, other than as described in this paragraph, the benefits and amounts that will be received by each of the officers named in the Summary Compensation Table above, the executive officers as a group and all other employees under the amended and restated 1995 Plan are not presently determinable.
15
Equity Compensation Plan Information
The following table sets forth certain information as to our equity compensation plans in effect as of January 31, 2003.
Number of securities | ||||||||||||
remaining available for | ||||||||||||
Number of securities to be | Weighted-average | future issuance under | ||||||||||
issued upon exercise of | exercise price of | equity compensation plans | ||||||||||
outstanding options, | outstanding options, | (excluding securities | ||||||||||
warrants and rights | warrants and rights | reflected in column (a)) | ||||||||||
Plan Category | (a) | (b) | (c) | |||||||||
Equity compensation plans approved by the
shareholders(1)
|
24,646,939 | $ | 17.20 | 5,691,676 | (2) | |||||||
Equity compensation plans not approved by the
shareholders(3)
|
160,039 | $ | 24.22 | | ||||||||
Total
|
24,807,248 | $ | 17.26 | 5,691,676 | ||||||||
(1) | Includes our 1995 Stock Option Plan, our 1997 Directors Stock Option Plan and our 2000 Employee Stock Purchase Plan. Under the 1997 Directors Stock Option Plan, each new non-employee director receives an option to purchase 30,000 shares of Common Stock upon joining the Board of Directors and each incumbent non-employee director is granted an option to purchase an additional 6,000 shares on the date of each annual general meeting, provided that on such date the director has served on the board for at least six months prior to the date of such annual general meeting. This plan is more fully described on page 20 of this Proxy Statement under Board of Directors Meetings and Attendance and Compensation. Includes 1,037,608 shares available for purchase pursuant to our 2000 Employee Stock Purchase Plan, which is more fully described on page 9 of this Proxy Statement under Approval of Amendment to the 2000 Employee Stock Purchase Plan. Also includes 3,944,058 shares of Common Stock reserved for issuance under option plans assumed by the Company in connection with the Companys acquisition of Galileo Technology Ltd. No further options will be awarded under the Galileo option plans. |
(2) | The number of shares reserved for grant under the 1995 Stock Option Plan and under the 2000 Employee Stock Purchase Plan are subject to an annual increase in shares reserved for issuance as described on page 12 under Approval of Amended and Restated 1995 Stock Option Plan and on page 9 under Approval of Amendment to the 2000 Employee Stock Purchase Plan, respectively. |
(3) | Includes 160,309 shares of Common Stock reserved for issuance under the options granted by the Company to former optionholders of SysKonnect GmbH in connection with the Companys acquisition of SysKonnect GmbH. |
Board Recommendation and Required Vote
The Board of Directors recommends a vote FOR the approval of the amendment and restatement of the Companys 1995 Plan. The affirmative vote of the holders of a majority of shares of Common Stock represented and voting at a duly held meeting at which a quorum is present is required to approve the amendment and restatement of the 1995 Plan. Unless marked to the contrary, proxies received will be voted FOR approval of the amendment and restatement of the Companys 1995 Plan.
16
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth information regarding the beneficial ownership of the Common Stock as of May 2, 2003 except as noted otherwise, for:
| each person known by the Company to own beneficially more than 5% of the Companys outstanding shares; | |
| each director, director nominee and executive officer named in the Summary Compensation Table on page 22 of this proxy statement; and | |
| all directors and executive officers as a group. |
Unless otherwise indicated, the address of each person owning more than 5% of our outstanding shares is c/o Marvell Semiconductor, Inc., 700 First Avenue, Sunnyvale, CA 94089.
Shares Beneficially | |||||||||
Owned(1) | |||||||||
Name and Address of Beneficial Owner | Number | Percent** | |||||||
5% Shareholders
|
|||||||||
Entities affiliated with Putnam Investments(2)
|
12,744,713 | 10.4 | % | ||||||
One Post Office Square
|
|||||||||
Boston, MA 02109
|
|||||||||
Entities affiliated with AXA Assurances I.A.R.D.
Mutuelle(3)
|
21,664,046 | 17.8 | % | ||||||
Directors and Executive Officers
|
|||||||||
Dr. Sehat Sutardja, Ph.D.(4)
|
23,582,312 | 19.3 | % | ||||||
Weili Dai(5)
|
23,557,312 | 19.3 | % | ||||||
Dr. Pantas Sutardja, Ph.D.(6)
|
11,501,000 | 9.4 | % | ||||||
George Hervey(7)
|
338,983 | * | |||||||
Manuel Alba(8)
|
531,764 | * | |||||||
Diosdado P. Banatao(9)
|
4,861,075 | 3.9 | % | ||||||
635 Waverley Street
|
|||||||||
Palo Alto, CA 94301
|
|||||||||
Kuo Wei (Herbert) Chang(10)
|
1,502,251 | 1.2 | % | ||||||
3600 Pruneridge Avenue, Suite 300
|
|||||||||
Santa Clara, CA 95051
|
|||||||||
Dr. John M. Cioffi, Ph.D.(11)
|
232,000 | * | |||||||
Dr. Paul R. Gray, Ph.D.(12)
|
142,000 | * | |||||||
Ron Verdoorn(13)
|
354,312 | * | |||||||
Executive officers and directors as a group
(10 persons)(14)
|
66,617,686 | 53.8 | % |
* | Less than one percent. |
** | The percentage of beneficial ownership for the following table is based on 122,039,100 shares of the common stock outstanding on May 2, 2003. |
(1) | Unless otherwise indicated, to the Companys knowledge, all persons listed have sole voting and investment power with respect to their shares of common stock, except to the extent authority is shared by spouses under applicable law. The number of shares beneficially owned by each shareholder is determined in accordance with the rules of the Securities and Exchange Commission and are not necessarily indicative of beneficial ownership for any other purpose. Under these rules, beneficial ownership includes those shares of common stock that the shareholder has sole or shared voting of investment power and any shares of common stock that the shareholder has a right to acquire within 60 days after May 2, 2003 through the exercise of any option, warrant or other right. The percentage ownership of the outstanding common stock, however, is based on the assumption, expressly required by the rules of the Securities and Exchange Commission, that only the person or entity whose ownership is being reported has converted options or warrants into shares of common stock. The amounts shown are based on information furnished by the people named. |
17
(2) | Based solely on information reported on a Schedule 13G/Amendment filed with the Securities and Exchange Commission on February 14, 2003 by Putnam, LLC d/b/a Putnam Investments, a wholly-owned subsidiary of Marsh & McLennan Companies, Inc. (M&MC), on behalf of itself, MM&C, Putnam Investment Management, LLC (PIM), The Putnam Advisory Company, LLC (PA) and Putnam New Opportunities Fund (PNOF). Includes 12,744,713 shares beneficially held by Putnam Investments, 381,026 shares for which it possesses shared voting power, and 12,744,713 shares for which it possesses shared dispositive power; 12,017,442 shares beneficially held by PIM, 122,015 shares for which it possesses shared voting power, and 12,017,442 shares for which it possess shared dispositive power; 727,271 shares beneficially held by PA, 259,011 shares for which it possesses shared voting power, and 727,271 shares for which it possesses shared dispositive power; 5,507,000 shares beneficially held by PNOF, 5,507,000 shares of which it possess shared dispositive power; and no shares beneficially held by M&MC. The principal business address of M&MC is 1166 Avenue of the Americas, New York, New York 10036. |
(3) | Based solely on information reported on a Schedule 13G/Amendment No. 1 filed with the Securities and Exchange Commission on February 12, 2003, by AXA Assurances I.A.R.D. Mutuelle, AXA Assurances Vie Mutuelle, AXA Conseil Vie Assurance Mutuelle, AXA Courtage Assurance Mutuelle, as a group (collectively, the Mutuelles AXA), AXA and AXA Financial, Inc. Each of the foregoing entities may be deemed to have sole voting power over 8,249,982 shares, shared voting power over 11,706,720 shares and sole dispositive power over 21,664,046 shares. The principal business address of AXA Conseil Vie Assurance Mutuelle, AXA Assurances I.A.R.D. Mutuelle and AXA Assurances Vie Mutuelle is 370, rue Saint Honore, 75001 Paris, France. The principal business address of AXA Courtage Assurance Mutuelle is 26, rue Louis le Grand, 75002 Paris, France. The principal business address of AXA is 25, avenue Matignon, 75008 Paris, France. The principal business address of AXA Financial, Inc. is 1290 Avenue of the Americas, New York, New York 10104. |
(4) | Dr. Sehat Sutardja and Ms. Dai are husband and wife. Consists of 50,000 shares subject to stock options that are currently exerciseable or will become exerciseable within 60 days after May 2, 2003; 8,670,000 shares held by Dr. Sutardja, of which Ms. Dai may be deemed to be a beneficial owner, although Ms. Dai disclaims such beneficial ownership; 8,670,000 shares held by Ms. Dai, of which Dr. Sutardja may be deemed to be a beneficial owner, although Dr. Sutardja disclaims such beneficial ownership; 92,312 shares jointly held by Dr. Sutardja and Ms. Dai; and 6,100,000 shares held by the Sutardja Family Partners of which Dr. Sutardja and Ms. Dai are the general partners. Dr. Sutardja and Ms. Dai disclaim beneficial ownership of the 6,100,000 shares held by the Sutardja Family Partners, except to the extent of their pecuniary interest, if any. |
(5) | Dr. Sehat Sutardja and Ms. Dai are husband and wife. Consists of 25,000 shares subject to stock options that are currently exerciseable or will become exerciseable within 60 days after May 2, 2003; 8,670,000 shares held by Dr. Sutardja, of which Ms. Dai may be deemed to be a beneficial owner, although Ms. Dai disclaims such beneficial ownership; 8,670,000 shares held by Ms. Dai, of which Dr. Sutardja may be deemed to be a beneficial owner, although Dr. Sutardja disclaims such beneficial ownership; 92,312 shares jointly held by Dr. Sutardja and Ms. Dai; and 6,100,000 shares held by the Sutardja Family Partners of which Dr. Sutardja and Ms. Dai are the general partners. Dr. Sutardja and Ms. Dai disclaim beneficial ownership of the 6,100,000 shares held by the Sutardja Family Partners, except to the extent of their pecuniary interest, if any. |
(6) | Includes 25,000 shares subject to stock options that are currently exerciseable or will become exerciseable within 60 days after May 2, 2003 and 4,000 shares held by Dr. Pantas Sutardjas mother-in-law. Dr. Pantas Sutardja disclaims beneficial ownership of the shares held by his mother-in-law, except to the extent of his pecuniary interest, if any. |
(7) | Includes 335,066 shares subject to stock options that are currently exercisable or will become exercisable within 60 days after May 2, 2003. |
(8) | Includes 21,690 shares held Mr. Albas wife. Mr. Alba disclaims beneficial ownership of the shares and shares subject to stock options held by his wife, except to the extent of his pecuniary interest, if any. |
18
(9) | Includes 1,111,700 shares subject to stock options that are currently exercisable or will become exercisable within 60 days after May 2, 2003; 1,676,747 shares held by the Diosdado and Maria C. Banatao Trust of which Mr. Banatao is co-trustee; 680,680 shares held by Tallwood Partners, of which the Diosdado and Maria C. Banatao Trust is the general partner; and 16,948 shares held by Mr. Banataos daughter. Mr. Banatao disclaims beneficial ownership of the shares held by his daughter, except to the extent of his pecuniary interest, if any. |
(10) | Includes 42,000 shares subject to stock options that are currently exercisable or will become exercisable within 60 days after May 2, 2003. Includes 210,000 shares held by InveStar Dayspring Venture Capital, Inc.; 50,000 shares held by InveStar Excelsus Venture Capital (Intl), Inc.; 400,000 shares held by InveStar Burgeon Venture Capital, Inc.; 184,616 shares held by Forefront Venture Partners, L.P.; 34,071 held by InveStar Avantgarde Holding Inc.; and 400,564 shares held by InveStar Capital, Inc. Mr. Chang is the President of InveStar Capital, Inc., which is the investment manager of each of InveStar Dayspring Venture Capital, Inc., InveStar Excelsus Venture Capital (Intl), Inc., InveStar Avantgarde Holding Inc. and InveStar Burgeon Venture Capital, Inc. Mr. Chang is also the managing director of Forefront Associates LLC, which is the general partner of Forefront Venture Partners, L.P. Mr. Chang disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest, if any. |
(11) | Includes 51,000 shares acquired upon exercise of an option to purchase shares, which shares will not be fully vested within 60 days after May 2, 2003, and which, until fully vested, are subject to repurchase by the Company in the event of termination of Dr. Cioffis services as a non-employee director of the Company and 42,000 shares subject to stock options that are current exercisable or will become exercisable within 60 days after May 2, 2003. |
(12) | Includes 134,000 shares subject to stock options that are currently exercisable or will become exercisable within 60 days after May 2, 2003. Of the 89,000 shares subject to stock options, the options with respect to 90,000 shares will not be fully vested within 60 days after May 2, 2003, and which, until fully vested, if exercised, would be subject to repurchase by the Company in the event of termination of Dr. Grays services as a non-employee director of the Company. |
(13) | Includes 42,000 shares subject to stock options that are currently exercisable or will become exercisable within 60 days after May 2, 2003 and 312,312 shares held by the Ron Verdoorn Family Trust of which Mr. Verdoorn is the trustee. |
(14) | Includes 51,000 shares acquired upon exercise of an option to purchase shares, which shares will not be fully vested within 60 days after May 2, 2003, and which, until fully vested, are subject to repurchase by the Company in the event of termination of the services of the applicable shareholder as a non-employee director of the Company and 1,768,966 shares subject to stock options that are currently exercisable or will become exercisable within 60 days after May 2, 2003. |
19
BOARD OF DIRECTORS AND COMMITTEES OF THE BOARD
Composition of the Board of Directors
The Companys Amended and Restated Bye-Laws provide for two or more directors, and the number of directors is currently fixed at nine directors. The number of directors currently appointed to the Board of Directors is nine. The Companys Board of Directors is divided into three classes, each serving staggered three-year terms, which means that only one class of directors is elected at each Annual General Meeting of Shareholders, with the other classes continuing for the remainder of their respective terms. Directors may only be removed for cause by a special resolution of the Company.
Board of Directors Meetings and Attendance and Compensation
Meetings of the Board of Directors
There were eight meetings of the Board of Directors in fiscal 2003. Each of the directors attended at least 75% of the total number of meetings of the Board of Directors and committees on which such director served.
Compensation of Directors
The Companys directors do not receive cash compensation for their service as directors or as members of any committee of the Board of Directors. Under the Companys 1997 Directors Stock Option Plan, each new non-employee director receives an option to purchase 30,000 shares of common stock upon joining the Board of Directors. The options vest over a period of five years, with 20% vesting on the first anniversary of the grant date, and 1.67% vesting each month thereafter provided that the non-employee director remains a director of the Company through such period. In addition, under the plan, each incumbent non-employee director is granted an option to purchase an additional 6,000 shares of Common Stock on the date of each annual general meeting of the Company, provided that on such date the director has served on the board for at least six months prior to the date of such annual general meeting. This option vests 20% on the day that is one month after the fourth anniversary of the grant date, and 8.3% vesting each month thereafter provided that the non-employee director remains a director of the Company through such period. The exercise price per share for each option is equal to the fair market value on the date of grant.
Committees of the Board of Directors and Attendance
The Companys Board of Directors has a standing Audit Committee, Compensation Committee and Stock Option Committee. The current membership of each committee is as follows, with the Chairman of the committee listed first in each case:
Audit Committee | Compensation Committee | Stock Option Committee | ||||
Diosdado P. Banatao
|
Diosdado P. Banatao | Dr. Sehat Sutardja, Ph.D. | ||||
Kuo Wei (Herbert) Chang
|
Kuo Wei (Herbert) Chang | Weili Dai | ||||
Ronald D. Verdoorn
|
Dr. John M. Cioffi, Ph.D. | |||||
Dr. Paul Gray, Ph.D. |
Audit Committee
The Audit Committees responsibilities are generally to assist the Board in fulfilling its legal and fiduciary responsibilities relating to accounting, audit and reporting policies and practices of the Company and its subsidiaries. The Audit Committee also, among other things, oversees the Companys financial reporting process, recommends to the Board of Directors the engagement of the Companys independent auditors, monitors and reviews the quality and activities of the Companys independent auditors, and monitors the adequacy of the Companys operating and internal controls as reported by management and internal auditors. The Board of Directors has adopted a written charter for the Audit Committee. The Board of Directors has determined that the members of the Audit Committee are independent as defined under the National
20
Compensation Committee
The Compensation Committee has the authority to approve salaries and bonuses and other compensation matters for the Companys executive officers, to approve employee health and benefit plans and to administer its stock option plans. The Compensation Committee held three meeting during fiscal 2003.
Stock Option Committee
The Stock Option Committee is authorized to make grants of stock options under the Companys 1995 Stock Option Plan to employees of the Company and to officers and general managers of each of the Companys subsidiaries. The Stock Option Committee held five meetings during fiscal 2003.
Nominations for Election of Directors
The Companys Board of Directors selects nominees for election as directors. The candidates for election at this Annual General Meeting were nominated by the Board of Directors. The Board of Directors will consider proposals for nomination from shareholders that are made in writing to the Secretary, that are timely and that contain sufficient background information concerning the nominee to enable proper judgment to be made as to his or her qualifications. See Shareholders Proposals For The 2004 Annual General Meeting on page 30.
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
The Companys Compensation Committee for fiscal 2003 consisted of the following members: Diosdado P. Banatao, Kuo Wei (Herbert) Chang, John M. Cioffi and Paul Gray. No member of the Compensation Committee is a current or former officer or employee of the Company or its subsidiaries or had any relationship to the Company requiring disclosure herein under the applicable rules of the Securities and Exchange Commission. In addition, to the Companys knowledge, there are no Compensation Committee interlocks between the Company and other entities, involving the Companys executive officers or Board members who serve as executive officers or board members of such other entities.
Management
Set forth below is certain information regarding the Companys executive officers together with the positions currently held by those persons, as of May 2, 2003. Dr. Sehat Sutardja, Weili Dai and Dr. Pantas Sutardja are the Companys other executive officers. As they are also directors, information for them is set forth beginning at page 4 of this Proxy Statement.
George Hervey joined Marvell in April 2000 as our Vice President of Finance and Chief Financial Officer, and serves in a similar capacity for Marvell Semiconductor, Inc. From March 1997 to April 2000, Mr. Hervey served as Senior Vice President, Chief Financial Officer and Secretary for Galileo Technology Ltd., which Marvell acquired in January 2001. From June 1992 to February 1997, Mr. Hervey was Senior Vice President and Chief Financial Officer of S3 Incorporated, a designer and manufacturer of graphics and video accelerators for personal computers and related peripheral products. Mr. Hervey holds a Bachelor of Science degree in Business Administration from the University of Rhode Island.
21
EXECUTIVE COMPENSATION
Summary Compensation Table
The following table shows the compensation for services rendered in all capacities to the Company for fiscal 2001, 2002 and 2003 paid or accrued to the Companys Chief Executive Officer and each of its three most highly compensated executive officers other than the Chief Executive Officer whose total salary and bonus for the fiscal year ended February 1, 2003 exceeded $100,000 (the Named Executive Officers). The Company did not make any restricted stock awards or long-term incentive plan payments in the fiscal year ended February 1, 2003. All amounts are in United States dollars.
Long Term | |||||||||||||||||||||
Annual | Compensation Awards | ||||||||||||||||||||
Compensation(1) | |||||||||||||||||||||
Securities Underlying | All Other | ||||||||||||||||||||
Name And Principal Positions | Fiscal Year | Salary($) | Bonus($) | Options(#) | Compensation(2) | ||||||||||||||||
Dr. Sehat Sutardja, Ph.D.
|
2003 | $ | 500,000 | $ | 13,000 | 200,000 | | ||||||||||||||
Co-Chairman of the Board,
|
2002 | $ | 250,000 | | | | |||||||||||||||
President and Chief
|
2001 | $ | 250,000 | | | $ | 1,628 | ||||||||||||||
Executive Officer
|
|||||||||||||||||||||
Weili Dai
|
2003 | $ | 375,000 | $ | 250 | 100,000 | | ||||||||||||||
Executive Vice President,
|
2002 | $ | 200,000 | | | | |||||||||||||||
Secretary and Director
|
2001 | $ | 200,000 | | | $ | 1,628 | ||||||||||||||
Dr. Pantas Sutardja, Ph.D.
|
2003 | $ | 300,000 | $ | 1,500 | 100,000 | | ||||||||||||||
Vice President and Director
|
2002 | $ | 230,000 | | | | |||||||||||||||
2001 | $ | 230,000 | | | $ | 1,628 | |||||||||||||||
George Hervey
|
2003 | $ | 221,760 | | 110,000 | | |||||||||||||||
Vice President of Finance
|
2002 | $ | 198,000 | | | | |||||||||||||||
and Chief Financial Officer
|
2001 | $ | 138,462 | | 800,000 | |
(1) | The amount of cash compensation does not include the aggregate value of personal benefits or securities, property or other non-cash compensation paid or distributed other than pursuant to a plan that was less than the lesser of $50,000 and 10% of the cash compensation received by such officer, which represents the threshold reporting requirement. |
(2) | These amounts consist of discretionary profits sharing payments. |
22
OPTION GRANTS IN LAST FISCAL YEAR
The following tables set forth certain information as of February 1, 2003 and for the fiscal year then ended with respect to stock options granted to and exercised by the named executive officers. The options granted to the named executive officers in fiscal year 2003 granted under the Companys 1995 Plan. Except for the grant of options to acquire 70,000 shares of Common Stock granted to the Companys Vice President and Chief Financial Officer, which option vests 100% on the fifth annual anniversary of the grant date, the options granted to the named executive officers vest as to 25% on the first anniversary of the grant date and ratably each month over the following three years. The percent of the total options set forth below is based on an aggregate of 7,434,850 options granted to employees during fiscal year 2003. All options were granted at the then fair market value as determined by the Companys Board of Directors on the date of grant.
Potential realizable value represents hypothetical gains that could be achieved for the options if exercised at the end of the option term assuming that the fair market value of the common stock on the date of grant appreciates at 5% and 10% over the option term (10 years) and that the option is exercised and sold on the last day of its option term for the appreciated stock price. The assumed 5% and 10% rates of stock price appreciation are provided in accordance with rules of the Securities and Exchange Commission and do not represent the Companys estimate or projection of the Companys future common stock price. The calculation includes the difference, if any, between the fair market value on the date of grant and the exercise price for such options. The hypothetical gains shown are net of the option exercise price but do not include deductions for taxes and other expenses payable upon exercise of the option or for sale of the underlying shares of common stock. Actual gains, if any, on stock option exercises will depend on the future performance of the Companys common stock, the officers continued employment through applicable vesting periods and the date on which the options are exercised.
OPTION GRANTS IN FISCAL YEAR-END 2003
Individual Grants | ||||||||||||||||||||||||
Potential Realizable Value | ||||||||||||||||||||||||
Number of | % of Total | at Assumed Annual Rates of | ||||||||||||||||||||||
Securities | Options | Stock Price Appreciation for | ||||||||||||||||||||||
Underlying | Granted to | Option Term | ||||||||||||||||||||||
Options | Employees in | Exercise Price | Expiration | |||||||||||||||||||||
Name | Granted(#) | 2003 | ($/Sh) | Date | 5%($) | 10%($) | ||||||||||||||||||
Dr. Sehat Sutardja, Ph.D.
|
200,000 | 2.7 | % | $ | 24.01 | 6/6/12 | $ | 3,019,952 | $ | 7,653,151 | ||||||||||||||
Weili Dai
|
100,000 | 1.3 | 24.01 | 6/6/12 | 1,509,976 | 3,826,576 | ||||||||||||||||||
Dr. Pantas Sutardja, Ph.D.
|
100,000 | 1.3 | 24.01 | 6/6/12 | 1,509,976 | 3,826,576 | ||||||||||||||||||
George Hervey
|
40,000 | 0.5 | 30.69 | 2/28/12 | 772,031 | 1,956,478 | ||||||||||||||||||
70,000 | 0.9 | 13.87 | 10/16/12 | 610,594 | 1,547,365 |
23
OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END OPTION VALUES
The following table shows the number of options exercised during fiscal 2003 and the number unexercised options previously granted to the named executive officers that were exercisable and unexercisable at February 1, 2003.
Number of Securities | ||||||||||||||||||||||||
Underlying Unexercised | Value of Unexercised | |||||||||||||||||||||||
Options at | In-the-Money Options at | |||||||||||||||||||||||
Shares | February 1, 2003(#) | February 1, 2003($) | ||||||||||||||||||||||
Acquired on | Value Realized | |||||||||||||||||||||||
Name | Exercise(#)(1) | ($)(1) | Exercisable | Unexercisable | Exercisable | Unexercisable | ||||||||||||||||||
Dr. Sehat Sutardja, Ph.D.
|
| | | 200,000 | | | ||||||||||||||||||
Weili Dai
|
| | | 100,000 | | | ||||||||||||||||||
Dr. Pantas Sutardja, Ph.D.
|
| | | 100,000 | | | ||||||||||||||||||
George Hervey
|
81,100 | $ | 1,617,672 | 279,399 | 472,001 | $ | 4,739,220 | $ | 7,527,258 |
(1) | Based on the closing market price of the purchased shares as quoted on the Nasdaq National Market on the exercise date less the option exercise price paid for those shares. |
Employment Contracts and Change-in-Control Arrangements
The Company does not have any employment agreements with any of its executive officers. Nor does the Company have any compensatory plan or arrangement that would result in any payments to any executive officers upon such officers resignation, retirement or other termination or from a change in control of the Company. Accordingly any of the Companys executive officers may resign at any time and the employment of any executive officer may be terminated at any time by the Board of Directors.
The Report of the Compensation Committee, the Report of the Audit Committee and the Stock Price Performance Graph that appear immediately below shall not be deemed to be soliciting material or to be filed with the Securities and Exchange Commission, nor shall it be incorporated by any general statement incorporating by reference this proxy statement into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates this information by reference and shall not otherwise be deemed filed under such Acts.
24
JOINT REPORT OF THE COMPENSATION AND STOCK OPTION COMMITTEES
To: The Board of Directors:
The responsibility of the Compensation Committee is to oversee compensation practices, levels and components for the Companys President and Chief Executive Officer, Executive Vice President, Vice President and Chief Financial Officer and Vice President and Chief Technology Officer. In this capacity, the Committee is responsible for reviewing salaries, benefits and other compensation, including any awards to such persons under any bonus plan as well as recommending compensation levels of persons designated as executive officers by the Board of Directors. The Stock Option Committee administers the Companys option plans and, in this role, is solely responsible for reviewing and recommending stock option grants to all of the Companys eligible employees, including its executive officers.
Overall Executive Compensation Philosophy
The Committees believe that the compensation programs for the Companys executive officers, should reflect the Companys performance and the value created for our shareholders by such persons efforts. In addition, the compensation programs should support the short-term and long-term strategic goals and values of the Company, reward individual contributions to the Companys success and reflect comparable market salaries for similar officers within the Companys industry.
The policy for the Committees is to provide these officers with compensation opportunities that are based upon their personal performance, the financial performance of the Company and their contribution to that performance, and that are competitive enough to attract and retain highly skilled individuals. Each officers compensation package may be comprised of the following three elements: (i) a base salary; (ii) long-term incentives through the award of stock options under the Companys stock option plans; and (iii) an award under an annual performance incentive plan.
For fiscal year 2003, the compensation package of Dr. Sehat Sutardja, Ms. Weili Dai and Dr. Pantas Sutardja each consisted of: (i) a base salary and (ii) an award of stock options under the Companys stock option plans.
The Company and the Committees currently do not endorse employment contracts and, therefore, none of the current executive officers of the Company is a party to an employment contract.
Annual Salary and Incentive Compensation Program
The principal factors that the Committees took into account in establishing the officers compensation packages for the 2003 fiscal year are described below. Either Committee may, however, in its discretion apply entirely different factors, such as different measures of financial performance, or create different compensation elements, in future fiscal years.
Base Salaries. The base salary for each executive officer was generally established by the Compensation Committee on the basis of relative parity with other executive officers of the Companys industry.
Stock Option Grants. The Company does not offer a long-term cash incentive plan. To reward executives on a long-term basis, stock options have been granted to provide the equity link to shareholders. Stock options may be granted by the Compensation Committee to the Companys executive officers and the Stock Option Committee may grant other employees stock options under the Companys Amended and Restated 1995 Stock Option Plan. Because of the direct relationship between the value of an option and the stock price, the Compensation Committee believes that options motivate those executive officers granted options to manage the Company in a manner that is consistent with shareholder interests. Stock option grants are intended to focus the attention of the recipient on the Companys long-term performance, which the Company believes results in improved shareholder value, and to retain the services of the executive officers in a competitive job market by providing significant long-term earnings potential. To this end, stock options generally vest and become fully exercisable over a period of years. Initial option grants typically vest as follows: 20% of the total shares underlying the option on the first anniversary of the vesting commencement date and
25
Compensation of the President and CEO
The Compensation Committee has set the base salary of Dr. Sehat Sutardja at a level that it believes approximates the median of base salary level for the chief executive officers of those companies with which the Company competes for executive talent. It is the opinion of the Committees that each of their respective compensation policies and plans provide the necessary total remuneration program to properly align the interests of each of the foregoing executive officers and the interests of the Companys shareholders through the use of competitive and equitable executive compensation in a balanced and reasonable manner, for both the short and long-term.
Submitted by the Compensation and Stock Option Committees of the Companys Board of Directors:
April 22, 2003
COMPENSATION COMMITTEE
|
STOCK OPTION COMMITTEE | |
Diosdado P. Banatao | Dr. Sehat Sutardja, Ph.D. | |
Kuo Wei (Herbert) Chang | Weili Dai | |
Dr. John M. Cioffi, Ph.D. | ||
Dr. Paul R. Gray, Ph.D. |
26
REPORT OF THE AUDIT COMMITTEE
To: The Board of Directors
As members of the Audit Committee for the 2003 fiscal year, we are responsible for representing the Board of Directors in discharging its responsibilities relating to the accounting, reporting, and financial practices of the Company and its subsidiaries, and have general responsibility for overseeing the system of internal controls and accounting and audit activities of the Company and its subsidiaries. The Board of Directors has determined that each member of the Audit Committee is an independent director as defined under the rules of National Association of Securities Dealers.
A copy of the Companys amended and restated Audit Committee Charter was attached as Appendix C to the Companys proxy statement filed in connection with the Companys 2001 Annual General Meeting of Shareholders.
The Audit Committee has reviewed and discussed with management and the independent auditors the audited financial statements of the Company. Management has the primary responsibility for the financial statements and the reporting process of the Company. PricewaterhouseCoopers LLP, the Companys independent auditors, are responsible for expressing an opinion on the conformity of the Companys audited financial statements to generally accepted accounting principles.
The Audit Committee has discussed with PricewaterhouseCoopers the matters required to be discussed by Statements on Auditing Standards No. 61 (Communication with Audit Committees). In addition, PricewaterhouseCoopers has provided to the Audit Committee the written disclosures and the letter required by Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees) and the Audit Committee discussed with PricewaterhouseCoopers their independence from the Company and its management. The Audit Committee also considered PricewaterhouseCoopers provision of non-audit services to the Company and determined that such provision of such services was compatible with maintaining the independence of PricewaterhouseCoopers.
Based on the review and discussions referred to above, the Audit Committee recommended, and the Board of Directors approved, that the audited financial statements be included in the Companys Annual Report on Form 10-K for the year ended February 1, 2003, for filing with the Securities and Exchange Commission and that PricewaterhouseCoopers be nominated for appointment as independent auditors for the Company for fiscal 2004, subject to the approval thereof by the Companys shareholders at the Companys next Annual General Meeting of Shareholders.
April 22, 2003
AUDIT COMMITTEE
27
INFORMATION CONCERNING INDEPENDENT AUDITORS
PricewaterhouseCoopers LLP, independent public accountants, have been the auditors for the financial statements of the Company for each year since 1997. Representatives of PricewaterhouseCoopers will be present at the 2003 Annual General Meeting, and they will be given an opportunity to make a statement if they desire to do so and will be available to respond to any appropriate questions from shareholders.
In addition to retaining PricewaterhouseCoopers to audit the consolidated financial statements for fiscal 2003, the Company and its subsidiaries retained PricewaterhouseCoopers to provide various other services in fiscal 2003. The aggregate fees for professional services by PricewaterhouseCoopers in fiscal 2003 for these various services were:
Audit Fees
The aggregate audit fees billed or to be billed by PricewaterhouseCoopers LLP for each of the last two fiscal years for professional services rendered for the audit of the Companys annual financial statements, review of financial statements included in the Companys quarterly reports on Form 10-Q and services that were provided in connection with statutory and regulatory filings or engagements were approximately $636,000 for fiscal 2003 and $562,000 for fiscal 2002.
Audit-Related Fees
The aggregate fees billed or to be billed by PricewaterhouseCoopers LLP in each of the last two fiscal years for assurance and related services that were reasonably related to the performance of the audit or review of the Companys financial statements were $0 for fiscal 2003 and $0 for fiscal 2002.
Tax Fees
The aggregate fees billed or to be billed by PricewaterhouseCoopers LLP in each of the last two fiscal years for professional services related to tax advice, tax compliance, tax planning and foreign tax matters were $373,000 for fiscal 2003 and $39,000 for fiscal 2002.
All Other Fees
The aggregate fees billed or to be billed by PricewaterhouseCoopers LLP in each of the last two fiscal years for services and products other than those reported in the categories above were $10,000 for fiscal 2003 and $15,000 for fiscal 2002. The nature of the other services included subscription to an accounting, auditing and reporting library and other miscellaneous services.
Policy on Pre-Approval of Retention of Independent Auditors
The engagement of PricewaterhouseCoopers LLP for non-audit accounting and tax services performed for the Company is limited to those circumstances where these services are considered integral to the audit services that it provides or in which there is another compelling rationale for using its services. Pursuant to the Sarbanes-Oxley Act of 2002, all audit and permitted non-audit services for which the Company engages PricewaterhouseCoopers LLP after May 6, 2003 require pre-approval by the Audit Committee.
As noted in the report of the Audit Committee at page 27 of this proxy statement, the Audit Committee considered the provision by PricewaterhouseCoopers LLP of non-audit services to the Company and determined that the provision of these services was compatible with maintaining the independence of PricewaterhouseCoopers LLP.
28
STOCK PRICE PERFORMANCE GRAPH
The graph below compares the cumulative total shareholder return of the Companys common stock with the cumulative total return of the S&P 500 Index, the JP Morgan H&Q Technology Index and the Philadelphia Semiconductor Index since June 27, 2000, when the Companys common stock was first registered under the Exchange Act, through February 1, 2003. The Company has added the Philadelphia Semiconductor Index this year because the JP Morgan H&Q Technology Index ceased publication in March 2002. In accordance with the rules of the Securities and Exchange Commission, the Company has continued to include the JP Morgan H&Q Technology Index through the end of its fiscal 2002. The graph assumes that $100 was invested at the time of the Companys initial public offering on June 27, 2000 in the Companys common stock and each index and that any dividends were reinvested. No cash dividends have been declared on the Companys common stock since the initial public offering. The comparisons in the table are required by the Securities and Exchange Commission and are not intended to forecast or be indicative of possible future performance of the Companys common stock.
COMPARISON OF 31 MONTH CUMULATIVE TOTAL RETURN*
TOTAL RETURN ANALYSIS | 6/27/00 | 1/26/01 | 2/02/02 | 2/01/03 | ||||||||||||
MARVELL TECHNOLOGY GROUP LTD.
|
100.00 | 61.92 | 70.99 | 32.36 | ||||||||||||
S&P 500
|
100.00 | 96.85 | 81.21 | 62.52 | ||||||||||||
JP MORGAN H&Q TECHNOLOGY
|
100.00 | 74.50 | 43.57 | |||||||||||||
PHILADELPHIA SEMICONDUCTOR
|
100.00 | 57.26 | 49.06 | 23.52 |
29
RELATED PARTY TRANSACTIONS
Since February 1, 2001, there has not been nor is there currently proposed any transaction or series of similar transactions to which Marvell was or will be a party in which the amount involved exceeded or will exceed $60,000 and in which any director, executive officer, holder of more than 5% of Marvells stock or any member of his or her immediate family had or will have a direct or indirect material interest, except as noted below.
In October 2001, the Company entered into a lease agreement with a privately-held design technology firm for certain computer-aided design software. The Company selected this product after an evaluation of competitive products on the strength of its merits. One of the officers of the design technology firm is the brother of an officer and director of Marvell and is also a shareholder of Marvell. The design technology firm was acquired by Cadence Design Systems in December 2001 and the lease agreement was subsequently amended in 2002. Total principal, interest and maintenance payments over the 3 1/2 year term of the lease agreement will be $20.7 million.
SHAREHOLDER PROPOSALS FOR THE 2004 ANNUAL GENERAL MEETING
Under United States federal securities laws, any proposal of an eligible shareholder of the Company that such shareholder wishes to have considered for inclusion in the Companys proxy solicitation materials relating to the Companys 2004 Annual General Meeting of Shareholders must be received by the Company at its principal executive offices no later than January 24, 2004. Under United States Federal Securities Laws, a shareholder is eligible to present proposals to the Board of Directors if he or she is the record or beneficial owner of at least one percent or $2,000 in market value of securities entitled to be voted at the 2004 Annual General Meeting and has held such securities for at least one year, and he or she continues to own such securities through the date on which the meeting is held.
Although information received after such date will not be included in proxy materials sent to shareholders, a shareholder proposal for the nomination of directors may still be presented at the Annual General Meeting if such proposal complies with the Companys Bye-Laws then in effect. In accordance with Bye-law 34 of the Companys Amended and Restated Bye-Laws currently in effect, shareholder nominations for election of directors may be voted on at an Annual General Meeting only if such nominations are made pursuant to written notice timely given to the Corporate Secretary accompanied by certain information. To be timely, a shareholders written notice must be received at the principal executive offices of the Company not earlier than the 90th day prior to anniversary of the prior years Annual General Meeting nor later than the 60th day prior to such anniversary. Under Bye-Laws 12(5)(b) and 34 of the Companys Second Amended and Restated Bye-laws, to be timely the shareholders written notice must be received by the Company not less than 60 nor more than 180 days prior to the date set for annual meeting (or if no such date is set, the date that is not less than 60 nor more than 180 days prior to the anniversary of the previous years annual meeting). The notice must contain the name and business background of any person being nominated by such shareholder as a director and all material information on any proposal, statement or resolution to be put to the meeting and details of the shareholder submitting the proposal, statement or resolution, as well as other information that may be specified by the Board of Directors. The Board of Directors will review proposals from eligible shareholders which it receives by that date and will determine whether any such proposal has been received in accordance with the Companys Bye-Laws then in effect and whether any such proposal will be acted upon at the Annual General Meeting.
All shareholder proposals should be sent to the Secretary at the Companys principal executive offices located at 4th Floor, Windsor Place, 22 Queen Street, P.O. Box HM 1179, Hamilton HM EX, Bermuda.
In addition, Section 79 of the Companies Act 1981 of Bermuda, provides that shareholders representing either: (1) 5% of the total voting power of the shares of common stock eligible to vote at a general meeting of the Company; or (2) not less than one hundred shareholders; may propose any resolution which may be properly be moved at the next Annual General Meeting of the Company; or circulate a statement with respect to any matter referred to in a proposed resolution at the next Annual General Meeting of the Company. To be
30
OTHER MATTERS
At the time of preparation of this proxy statement, the Board of Directors of the Company was not aware of any other matters to be brought before the Annual General Meeting. No eligible shareholder had submitted notice of any proposal before the printing and mailing of this proxy statement. However, if any other matters are properly presented for action, in the absence of instructions to the contrary, it is the intention of the persons named in the enclosed form of proxy to vote, or refrain from voting, in accordance with their respective best judgment on such matters.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Pursuant to Section 16(a) of the Exchange Act and the rules promulgated thereunder and requirements of the National Association of Securities Dealers, officers and directors of the Company and persons who beneficially own more than 10% of the common stock of the Company are required to file with the SEC and the NASD and furnish to the Company reports of ownership and change in ownership with respect to all equity securities of the Company.
Based solely on its review of the copies of such reports received by it during or with respect to the fiscal year ended February 1, 2003, and written representations from such reporting persons, the Company believes that its officers, directors and 10% shareholders complied with all Section 16(a) filing requirements applicable to such individuals with the exception of the following late filings: (a) Dr. Pantas Sutardja was late filing his Form 4 with respect to one transaction, which was subsequently reported on a Form 4; (b) Mr. Manuel Alba omitted shares held that should have been reported on his Form 3 dated January 31, 2001, which were subsequently reported on a Form 4 and (c) Mr. Diosdado Banatao failed to report a transaction which was subsequently reported on a Form 4.
31
ANNUAL REPORT ON FORM 10-K
Along with this proxy statement, the Company has provided each shareholder entitled to vote, a copy of its Annual Report on Form 10-K for the year ended February 1, 2003 without the exhibits thereto. The Company will provide, without charge, a copy of its 2003 Form 10-K, or a copy of the exhibits to its 2003 Form 10-K, upon the written or oral request of any shareholder or beneficial owner of common stock. Requests should be directed to the following address:
Marvell Semiconductor, Inc.
By order of the board of directors, | |
WEILI DAI | |
Secretary |
Sunnyvale, California
PLEASE SIGN, DATE AND RETURN THE ENCLOSED PROXY CARD PROMPTLY.
32
The Annual General Meeting of Shareholders
of
Marvell Technology Group Ltd.
will be held at the offices of
on
DIRECTIONS:
FROM SAN FRANCISCO AIRPORT: Take the 101 South. Take the Highway 237 exit East. Take the Mathilda Avenue exit North. Turn left onto 3rd Avenue. Turn right into the Marvell parking lot. (approximate time 30 minutes)
FROM SAN JOSE AIRPORT: Take the 101 North. Take the Mathilda Avenue North exit. Turn left onto 3rd Avenue. Turn right into the Marvell parking lot. (approximate time 15 minutes)
Appendix A
MARVELL TECHNOLOGY GROUP LTD.
AMENDED
2000 EMPLOYEE STOCK PURCHASE
PLAN
(As amended through May 7, 2003)
1. Purpose. This Plan is intended to allow Employees of the Company and its Designated Subsidiaries to purchase Common Stock through accumulated Payroll deductions.
2. Defined Terms. The meanings of defined terms (generally, capitalized terms) in this Plan are provided in Section 23 (Glossary).
3. Eligibility.
(a) Participation. Any person who is an Employee on an Offering Date shall be eligible to participate in this Plan during the corresponding Offering Period.
(b) No Participation by Five-Percent Stockholders. Notwithstanding Section 3(a), an Employee shall not participate in this Plan during an Offering Period if immediately after the grant of a Purchase Right on the Offering Date, the Employee (or any other person whose stock would be attributed to the Employee under Section 424(d) of the Code) would own stock possessing five percent or more of the total combined voting power or value of all classes of stock of the Company or of any Subsidiary. For this purpose, an Employee is treated as owning stock that he or she could purchase by exercise of Purchase Rights or other options.
4. Offering Periods. Except as otherwise determined by the Administrator:
(a) the first Offering Period under this Plan shall begin on the first business day before the effective date of a firmly underwritten initial public offering of Common Stock and shall end on the last trading day of January of the second succeeding calendar year;
(b) a new Offering Period shall begin on the first business day of each February and August while this Plan is in effect;
(c) the duration of each Offering Period (other than the first Offering Period) shall be 24 months (measured from the first business day of the first month to the last business day of the 24th month); and
(d) an Offering Period shall terminate on the first date that no Participant is enrolled in it.
5. Participation.
(a) An Employee may become a Participant in this Plan by completing a subscription agreement, in such form as the Administrator may approve from time to time, and delivering it to
the Administrator by 1 p.m. Pacific time on the applicable Offering Date, unless another time for filing the subscription agreement is set by the Administrator for all Employees with respect to a given Offering Period. The subscription agreement shall authorize Payroll deductions pursuant to this Plan and shall have such other terms as the Administrator may specify from time to time.
(b) At the end of an Offering Period, each Participant in the Offering Period who remains an Employee shall be automatically enrolled in the next succeeding Offering Period (a Re-enrollment) unless, in a manner and at a time specified by the Administrator, but in no event later than 1 p.m. Pacific time on the Offering Date of such succeeding Offering Period, the Participant notifies the Administrator in writing that the Participant does not wish to be re-enrolled. Re-enrollment shall be at the withholding percentage specified in the Participants most recent subscription agreement. No Participant shall be automatically re-enrolled whose participation has terminated by operation of Section 10.
(c) If the fair market value of the Common Stock on any Offering Date is less it was on the first day of a then-concurrent Offering Period, each Participant in the concurrent Offering Period shall automatically be withdrawn from such concurrent Offering Period and shall become a Participant in the commencing Offering Period. Participation shall be at the withholding percentage specified in the Participants most recent (as of 1 p.m. Pacific time on the relevant Offering Date) subscription agreement. No Participant shall be automatically re-enrolled whose participation in this Plan has terminated by operation of Section 10.
6. Payroll Deductions.
(a) Payroll deductions under this Plan shall be in whole percentages, from a minimum of 1% up to a maximum (not to exceed 20%) established by the Administrator from time to time, as specified by the Participant in his or her subscription agreement in effect on the first day of an Offering Period. Payroll deductions for a Participant shall begin with the first payroll payment date of the Offering Period and shall end with the last payroll payment date of the Offering Period, unless sooner terminated by the Participant as provided in Section 10.
(b) A Participants Payroll deductions shall be credited to his or her account under this Plan. A Participant may not make any additional payments into his or her account.
(c) A Participant may reduce his or her Payroll deductions by any whole percentage (but not below 1%) at any time during an Offering Period, effective 15 days after the Participant files with the Administrator a new subscription agreement authorizing the change. A Participant may change his or her Payroll deductions during an Offering Period, effective the first business day after a Purchase Date, by delivering a new subscription agreement authorizing the change to the Administrator by 1 p.m. Pacific time on the effective date of the increase.
7. Purchase Rights.
(a) Grant of Purchase Rights. On the Offering Date of each Offering
Period, the Participant shall be granted a Purchase Right to purchase during
the Offering Period the number of shares of Common Stock determined by dividing
(i) $25,000 multiplied by the number of (whole or part)
2
Table of Contents
calendar years in the Offering Period by (ii) the fair market value of a share of Common Stock on the Offering Date.
(b) Terms of Purchase Rights. Except as otherwise determined by the Administrator, each Purchase Right shall have the following terms:
(i) The per-share price of the shares subject to a Purchase Right shall be 85% of the lower of the fair market values of a share of Common Stock on (a) the Offering Date on which the Purchase Right was granted and (b) the Purchase Date. The fair market value of the Common Stock on a given date shall be the closing price as reported in the Wall Street Journal; provided, however, that if there is no public trading of the Common Stock on that date, then fair market value shall be determined by the Administrator in its discretion. | |
(ii) Payment for shares purchased by exercise of Purchase Rights shall be made only through Payroll deductions under Section 6. | |
(iii) Upon purchase or disposition of shares acquired by exercise of a Purchase Right, the Participant shall pay, or make provision satisfactory to the Administrator for payment of, all tax (and similar) withholdings that the Administrator determines, in its discretion, are required due to the acquisition or disposition, including without limitation any such withholding that the Administrator determines in its discretion is necessary to allow the Company and its Subsidiaries to claim tax deductions or other benefits in connection with the acquisition or disposition. | |
(iv) During his or her lifetime, a Participants Purchase Right is exercisable only by the Participant. | |
(v) Purchase Rights will in all respects be subject to the terms and conditions of this Plan, as interpreted by the Administrator from time to time. |
8. Purchase Dates; Purchase of Shares; Refund of Excess Cash.
(a) The Administrator shall establish one or more Purchase Dates for each Offering Period. Unless otherwise determined by the Administrator, the last trading day of each January and July in an Offering Period shall be a Purchase Date.
(b) Except as otherwise determined by the Administrator, and subject to subsection (c), below, each then-outstanding Purchase Right shall be exercised automatically on each Purchase Date, following addition to the Participants account of that days Payroll deductions, to purchase the maximum number of full shares of Common Stock at the applicable price using the Participants accumulated Payroll deductions.
(c) If on a Purchase Date the fair market value of the Common Stock is
less than 75% of the fair market value of the Common Stock on the immediately
preceding Purchase Date
3
Table of Contents
(whether or not such preceding Purchase Date is in the same Offering Period) (the Benchmark Date), then (except as otherwise determined by the Administrator):
(i) the maximum number of shares that a Participant may purchase on the Purchase Date shall be determined by multiplying the fair market value of the Common Stock on the Benchmark Date by 0.6375 and then dividing the Participants accumulated Payroll deductions by the result; | |
(ii) a maximum number of shares established pursuant to the clause (i) shall remain the maximum number of shares purchasable by a Participant on any subsequent Purchase Date until the Purchase Date on which the fair market value of the Common Stock is at least 75% of the fair market value of the Common Stock on the Benchmark Date; and | |
(iii) notwithstanding the foregoing, during the initial Offering Period under this Plan, the Benchmark Date shall be date of the beginning such Offering Period. |
(d) The shares purchased upon exercise of a Purchase Right shall be deemed to be transferred to the Participant on the Purchase Date.
9. Registration and Delivery of Share Certificates.
(a) Shares purchased by a Participant under this Plan will be registered in the name of the Participant, or in the name of the Participant and his or her spouse, or in the name of the Participant and joint tenant(s) (with right of survivorship), as designated by the Participant.
(b) As soon as administratively feasible after each Purchase Date, the Company shall deliver to the Participant a certificate representing the shares purchased upon exercise of a Purchase Right. If approved by the Administrator in its discretion, the Company may instead (i) deliver a certificate (or equivalent) to a broker for crediting to the Participants account or (ii) make a notation in the Participants favor of non-certificated shares on the Companys stock records.
10. Withdrawal; Termination of Employment.
(a) A Participant may withdraw all, but not less than all, the Payroll deductions credited to his account under this Plan before a Purchase Date by giving written notice to the Administrator, in a form the Administrator prescribes from time to time, at least 15 days before the Purchase Date. Payroll deductions will then cease as to the Participant, no purchase of shares will be made for the Participant on the Purchase Date, and all Payroll deductions then credited to the Participants account will be refunded promptly.
(b) Upon termination of a Participants Continuous Employment for any
reason, including retirement or death, all Payroll deductions credited to the
Participants account will be promptly refunded to the Participant or, in the
case of death, to the person or persons entitled thereto under Section 14, and
the Participants Purchase Right will automatically terminate.
4
(c) A Participants withdrawal from an offering will not affect the
Participants eligibility to participate in a succeeding offering or in any
similar plan that may be adopted by the Company.
11. Use of Funds; No Interest. Amounts withheld from Participants under
this Plan shall constitute general funds of the Company, may be used for any
corporate purpose, and need not be segregated from other funds. No interest
shall accrue on a Participants Payroll deductions.
12. Number of Shares Reserved.
(a) The following numbers of shares of Common Stock are reserved for
issuance under this Plan, and such number may be issued at any time before
termination of this Plan:
(b) If the total number of shares that would otherwise be subject to
Purchase Rights granted on an Offering Date exceeds the number of shares then
available under this Plan (after deduction of all shares for which Purchase
Rights have been exercised or are then exercisable), the Administrator shall
make a pro-rata allocation of the available shares in a manner that it
determines to be as uniform and equitable as practicable. In such event, the
Administrator shall give written notice of the reduction and allocation to each
Participant.
(c) The Administrator may, in its discretion, transfer shares reserved
for issuance under this Plan into a plan or plans of similar terms, as approved
by the Board, providing for the purchase of shares of Common Stock to employees
of Subsidiaries designated by the Board that do not (or do not thereafter)
participate in this Plan. Such additional plans may, without
limitation, provide for variances from the terms of this Plan to take into
account special circumstances (such as foreign legal restrictions) affecting
the employees of the designated Subsidiaries.
13. Administration. This Plan shall be administered by the Board or by
such directors,
officers, and employees of the Company as the Board may select from time to
time (the Administrator). All costs and expenses incurred in administering
this Plan shall be paid by the Company, provided that any taxes applicable to
an Employees participation in this Plan may be charged to the Employee by the
Company. The Administrator may make such rules and regulations as it deems
necessary to administer this Plan and to interpret any provision of this Plan.
Any determination, decision, or action of the Administrator in connection with
the construction, interpretation, administration, or application of this Plan
or any right granted under this Plan shall be final, conclusive, and binding
upon all persons, and no member of the Administrator shall be liable for any
such determination, decision, or action made in good faith.
5
14. Designation of Beneficiary.
(a) A Participant may file a written designation of a beneficiary who is
to receive any shares and cash, if any, from the Participants account under
this Plan in the event of the Participants death.
(b) A designation of beneficiary may be changed by the Participant at any
time by written notice. In the event of the death of a Participant, and in the
absence of a beneficiary validly designated under this Plan who is living at
the time of the Participants death, the Administrator shall deliver such
shares and/or cash to the executor or administrator of the Participants
estate, or if no such executor or administrator has been appointed (to the
Administrators knowledge), the Administrator, in its discretion, may deliver
such shares and/or cash to the spouse or to any one or more dependents or
relatives of the Participant or, if no spouse, dependent, or relative is known
to the Administrator, then to such other person as the Administrator may
designate.
15. Transferability. Neither Payroll deductions credited to a
Participants account nor any
rights with regard to the exercise of a Purchase Right or to receive shares
under this Plan may be assigned, transferred, pledged, or otherwise disposed of
in any way (other than by will, the laws of descent and distribution, or as
provided in Section 14) by the Participant. Any such attempt at assignment,
transfer, pledge, or other disposition shall be without effect, except that the
Administrator may treat such act as an election to withdraw funds in accordance
with Section 10.
16. Reports. Individual accounts will be maintained for each Participant
in this Plan.
Statements of account will be given to participating Employees promptly
following each Purchase Date, setting forth the amounts of Payroll deductions,
per-share purchase price, number of shares purchased, and remaining cash
balance, if any.
17. Adjustments upon Changes in Capitalization.
(a) Subject to any required action by the stockholders of the Company,
the number of shares of Common Stock covered by each unexercised Purchase Right
and the number of shares of Common Stock authorized for issuance under this
Plan but not yet been placed under a Purchase Right (collectively, the
Reserves), as well as the price per share of Common Stock covered by each
unexercised Purchase Right, shall be proportionately adjusted for any change in
the number of issued shares of Common Stock resulting from a stock split,
reverse stock split, stock dividend, combination or reclassification of the
Common Stock, or any change in the number of shares of Common Stock effected
without receipt of consideration by the Company (not counting shares issued
upon conversion of convertible securities of the Company as effected without
receipt of consideration). Such adjustment shall made by the Board and shall
be final, binding, and conclusive. Except as expressly provided herein, no
issue by the Company of shares of stock of any class, or securities convertible
into shares of stock of any class, shall affect, and no consequent adjustment
shall be made with respect to, the number or price of shares of Common Stock
subject to a Purchase Right.
(b) In the event of the proposed dissolution or liquidation of the
Company, the then-current Offering Period will terminate immediately before the
consummation of the proposed
6
action, unless otherwise provided by the Board. In the event of a proposed sale
of all or substantially all of the Companys assets, or the merger of the
Company with or into another corporation (if the Companys stockholders own
less than 50% of the total outstanding voting power in the surviving entity or
a parent of the surviving entity after the merger), each Purchase Right under
this Plan shall be assumed or an equivalent purchase right shall be substituted
by the successor corporation or a parent or subsidiary of the successor
corporation, unless the successor corporation does not agree to assume the
Purchase Rights or to substitute equivalent purchase
rights, in which case the Board may, in lieu of such assumption or
substitution, accelerate the exercisability of Purchase Rights and allow
Purchase Rights to be exercisable as to shares as to which they would not
otherwise be exercisable, on terms and for a period that the Board determines
in its discretion. To the extent that the Board accelerates exercisability of
Purchase Rights as described above, it shall promptly so notify all
Participants in writing.
(c) The Board may, in its discretion, also make provision for adjusting
the Reserves, as well as the price per share of Common Stock covered by each
outstanding Purchase Right, if the Company effects one or more reorganizations,
recapitalizations, rights offerings, or other increases or reductions of shares
of its outstanding Common Stock, or if the Company consolidates with or merges
into any other corporation, in a transaction not otherwise covered by this
Section 17.
18. Amendment or Termination.
(a) The Board may at any time terminate or amend this Plan. No amendment
may be made without prior approval of the stockholders of the Company (obtained
in the manner described in Section 20) if it would increase the number of
shares that may be issued under this Plan.
(b) The Board may elect to terminate any or all outstanding Purchase
Rights at any time, except to the extent that exercisability of such Purchase
Rights has been accelerated pursuant to Section 17(b). If this Plan is
terminated, the Board may also elect to terminate Purchase Rights upon
completion of the purchase of shares on the next Purchase Date or to permit
Purchase Rights to expire in accordance with their terms (with participation to
continue through such expiration dates). If Purchase Rights are terminated
before expiration, any funds contributed to this Plan that have not been used
to purchase shares shall be refunded to Participants as soon as
administratively feasible.
19. Notices. All notices or other communications by a Participant to the
Company or the
Administrator under or in connection with this Plan shall be deemed to have
been duly given when received in the form specified by the Administrator at the
location, or by the person, designated by the Administrator for that purpose.
20. Stockholder Approval. This Plan shall be submitted to the
stockholders of the Company for their approval within 12 months after the date
this Plan is adopted by the Board.
21. Conditions upon Issuance of Shares.
7
(a) Shares shall not be issued with respect to a Purchase Right unless
the exercise of such Purchase Right and the issuance and delivery of such
shares pursuant thereto complies with all applicable provisions of law,
domestic or foreign, including, without limitation, the Securities Act of 1933,
as amended, the Securities Exchange Act of 1934, as amended, the rules and
regulations promulgated thereunder, and the requirements of any stock exchange
upon which the shares may then be listed, and shall be further subject to the
approval of counsel for the Company with respect to such compliance.
(b) As a condition to the exercise of a Purchase Right, the Company may
require the person exercising such Purchase Right to represent and warrant at
the time of any such exercise that the shares are being purchased only for
investment and without any present intention to sell or distribute such shares
if, in the opinion of counsel for the Company, such a representation is
required by any of the aforementioned applicable provisions of law.
22. Term of Plan. This Plan shall become effective upon the earlier of
its adoption by the
Board or its approval by the stockholders of the Company as described in
Section
20. It shall continue in effect for a term of 20 years unless sooner terminated
under Section 18.
23. Glossary. The following definitions apply for purposes of this Plan:
(a) Administrator means the Board or the persons appointed by the Board
to administer this Plan pursuant to Section 13.
(b) Board means the Board of Directors of the Company.
(c) Code means the Internal Revenue Code of 1986, as amended.
(d) Common Stock means the Common Stock of the Company.
(e) Company means Marvell Technology Group Ltd., a Bermuda corporation.
(f) Continuous Employment means the absence of any interruption or
termination of service as an Employee. Continuous Employment shall not be
considered interrupted in the case of a leave of absence agreed to in writing
by the Company, provided that either (i) the leave does not exceed 90 days or
(ii) re-employment upon expiration of the leave is guaranteed by contract or
statute.
(g) Designated Subsidiaries means the Subsidiaries that have been
designated by the Board from time to time in its sole discretion to participate
in this Plan.
(h) Employee means any person, including an officer, who is customarily
employed for at least 20 hours per week and five months per year by the Company
or one of its Designated Subsidiaries. Whether an individual qualifies as an
Employee shall be determined by the Administrator, in its sole discretion, by
reference to Section 3401(c) of the Code and the regulations promulgated
thereunder; unless the Administrator makes a contrary determination,
8
the Employees of the Company shall, for all purposes of this Plan, be those
individuals who satisfy the customary employment criteria set forth above and
are carried as employees by the Company or a Designated Subsidiary for regular
payroll purposes.
(i) Offering Date means the first business day of an Offering Period.
(k) Offering Period means a period established by the Administrator
pursuant to Section 4 during which Payroll deductions are accumulated from
Participants and applied to the purchase of Common Stock.
(l) Participant means an Employee who has elected to participate in
this Plan pursuant to Section 5.
(m) Payroll means all regular, straight-time gross earnings, exclusive
of payments for overtime, shift premium, incentive compensation or payments,
bonuses, and commissions.
(m) Plan means this Marvell Technology Group Ltd. 2000 Employee Stock
Purchase Plan.
(n) Purchase Date means such business days during each Offering Period
as may be established by the Administrator for the purchase of Common Stock
pursuant to Section 8.
(o) Purchase Right means a right to purchase Common Stock granted
pursuant to Section 7.
(p) Subsidiary means, from time to time, any corporation, domestic or
foreign, of which not less than 50% of the voting shares are held by the
Company or another Subsidiary of the Company.
9
Appendix B
MARVELL TECHNOLOGY GROUP LTD.
AMENDED AND RESTATED
1995 STOCK OPTION PLAN 1. Purpose. This Plan is intended to attract and retain the best
available individuals as Employees, Consultants and Outside Directors of the
Company and its Subsidiaries, to provide additional incentives to those
Employees, Consultants and Outside Directors, and to promote the success of the
Companys business.
2. Defined Terms. The meanings of defined terms (generally, capitalized
terms) in this Plan are provided in Section 21 (Glossary).
3. Shares Reserved. Subject to Section 14, Shares that may be issued
with respect to Awards granted under the Plan shall not exceed an aggregate of
60,260,394 Shares of Common Stock; provided however, that on the first business
day of each fiscal year starting January 31, 2004 or after, and continuing
until the earlier of January 31, 2013 or termination of the Plan, there shall
be added to this Plan the lesser of an additional (i) 10,000,000 shares of
Common Stock, or (ii) 5.0% of the outstanding shares of capital stock on such
date. The Shares may be authorized, but unissued, or reacquired Common Stock.
If an Award under the Plan expires or becomes unexercisable for any reason, the
Shares subject to such Award which have not been issued shall be available for
future issuance under this Plan. Shares retained to satisfy tax withholding
obligations do not reduce the number authorized for issuance.
4. Administration.
(a) In General. This Plan shall be administered by the Board or a
Committee appointed by the Board. Once appointed, a Committee shall
serve until otherwise directed by the Board. From time to time, the
Board may increase the size of the Committee and appoint additional
members, remove members (with or without cause) and appoint new members
in their stead, fill vacancies however caused, and terminate the
Committee and thereafter directly administer this Plan.
(b) Committee Composition. The Board may provide for administration of
this Plan with respect to Officers and directors of the Company by a Committee
constituted so as to satisfy:
A Committee appointed under this Section 4(b) may be separate from any
Committee appointed to administer this Plan with respect to Employees who are
neither Officers nor directors. Within the limitations of this Section 4(b),
any reference in the Plan to the Committee shall include such committee or
committees appointed pursuant to this Section 4.
(c) Powers of the Administrator. Subject to the provisions of this Plan
and in the case of a Committee, subject to the specific duties delegated by the
Board, the Administrator shall have the authority, in its sole and absolute
discretion:
(d) Administrators Decisions Binding. All decisions, determinations, and
interpretations of the Administrator shall be final and binding on all Grantees
and any other holders of any Awards, and no member of the Administrator shall
be liable for any such determination, decision, or interpretation made in good
faith.
5. Eligibility.
(a) General. Nonstatutory Stock Options may be granted to Employees,
Consultants and Outside Directors. Incentive Stock Options may be granted only
to Employees. Other Awards
may be granted to Employees and Consultants. An Employee or Consultant
who has been granted an Award may, if otherwise eligible, be granted additional
Awards.
2
(b) Limitations.
6. Term of Options. The term of each Option shall be determined by the
Administrator at the time of grant but shall not exceed ten years. In the case
of an ISO granted to an Optionee who, at the time of grant, owns stock
representing more than ten percent of the voting power of all classes of stock
of the Company or any Parent or Subsidiary, the Option term shall not exceed
five years.
7. Date of Option Grant. Unless otherwise determined by the
Administrator, the date of grant of an Option shall be the date on which the
Administrator completes the actions necessary to grant the Option. Notice of
the grant shall be given to the Optionee within a reasonable time after the
date of the grant.
8. Option Exercise Price and Form of Consideration.
(a) Price. The per-Share exercise price of an Option shall be determined
by the Administrator at the time of grant, but:
(b) Form of Payment. Payment for Shares upon exercise of an Option shall
be made in any lawful consideration approved by the Administrator and may,
without limitation, consist of
(1) cash, (2) check, (3) other Shares that have a Fair Market Value on the
date of payment equal to the aggregate exercise price of the Shares as to which
Option is exercised; provided, however, that the Optionee shall not surrender,
or attest to the ownership of, Shares in payment of the
3
Exercise Price if such
action would cause the Company to recognize compensation expense (or additional
compensation expense) with respect to the Option for financial reporting
purposes, (4) delivery by a broker or brokerage firm approved by the
Administrator of a properly executed exercise notice together with payment of
the exercise price and such other documentation as the Administrator shall
require, or (5) any combination of the foregoing. Notwithstanding the
foregoing, a form of payment shall not be available if the Administrator
determines, in its sole and absolute discretion, that such form of payment
could violate any law or regulation.
9. Option Exercise.
(a) Exercisability. Each Option shall be exercisable at such times and
under such conditions as determined by the Administrator at the time of grant.
(b) Vesting. Each Option and the corresponding Optioned Stock shall vest
at such times and under such conditions as determined by the Administrator at
the time of grant, and as are otherwise permissible under the terms of this
Plan, including without limitation, performance criteria with respect to the
Company and/or the Optionee.
(c) Fractional Shares. An Option may not be exercised for a fraction of a
Share.
(d) Manner of Exercise; Rights as a Shareholder. Unless otherwise allowed
by the Administrator, an Option shall be exercised by delivery to the Company
of all of the following: (i) written notice of exercise by the Optionee, in a
form approved by the Administrator and in accordance with the terms of the
Option, (ii) full payment for the Shares with respect to which the Option is
exercised, and (iii) payment (or provision for payment) of withholding taxes
pursuant to Subsection (g), below. Delivery of any of the foregoing may be by
electronic means approved by the Administrator. The Optionee shall be treated
as a shareholder of the Company with respect to the purchased Shares upon
completion of exercise of the Option.
(e) Optionee Representations. If Shares purchasable pursuant to the
exercise of an Option have not been registered under the Securities Act of
1933, as amended, at the time the Option is exercised, the Optionee shall, if
required by the Administrator, as a condition to exercise of all or any portion
of the Option, deliver to the Company an investment representation statement in
a form approved by the Administrator.
(f) Termination of Employment or Consulting Relationship. If an
Optionees Continuous Service terminates, the Optionee (or the Optionees
estate or heirs, if termination is due to death or the Optionee dies during the
post-termination exercise period of the Option) may exercise the Option, (i)
only within such period of time as is determined by the Administrator (but no
later than the expiration date for the Option determined by the Administrator
at the time of grant) and the Option shall terminate at the end of that period,
and (ii) unless otherwise determined by the Administrator, only to the extent
that the Optionee was entitled to exercise it at the date of termination.
(g) Tax Withholding. The Companys obligation to deliver Shares upon
exercise of an Option is subject to payment (or provision for payment
satisfactory to the Administrator) by the
4
Optionee of all federal, state, and
local income and employment taxes that the Administrator determines in its
discretion to be due as a result of the exercise of the Option or sale of the
Shares.
10. Rule 16b-3. Except to the extent determined by the Administrator,
Awards granted to persons subject to Section 16(b) of the Exchange Act shall
comply with Rule 16b-3 and shall contain such terms as may be required or
desirable to qualify Plan transactions for the maximum exemption from Section
16 of the Exchange Act.
11. Non-Transferability of Options. Options may not be sold, pledged,
assigned, hypothecated, transferred, or disposed of in any manner other than by
will or by the laws of descent or distribution and may be exercised, during the
lifetime of the Optionee, only by the Optionee.
12. Buyout of Options. The Administrator may at any time offer to buy out
an Option for a payment in cash or Shares, based on such terms and conditions
as the Administrator shall establish and communicate to the Optionee at the
time of the offer.
13. Other Awards. The Administrator may from time to time grant other
stock-based awards to eligible Employees and Consultants in such amounts, on
such terms and conditions, and for such consideration, including no
consideration or such minimum consideration as may be required by law, as it
shall determine and set forth in the applicable Grant Agreement, including
without limitation the following:
(a) Stock Appreciation Rights. The Administrator may from time to time
grant Awards of stock appreciation rights (SAR). An SAR entitles the Grantee
to receive, subject to the provisions of the Plan and the Grant Agreement, a
payment having an aggregate value equal to the product of (i) the excess of (A)
the Fair Market Value on the exercise date of one share of Common Stock over
(B) the base price per share specified in the Grant Agreement, times (ii) the
number of shares specified by the SAR, or portion thereof, which is exercised.
Payment by the Company of the amount receivable upon any exercise of an SAR may
be made by the delivery of Common Stock or cash, or any combination of Common
Stock and cash, as determined in the sole discretion of the Administrator. If
upon settlement of the exercise of an SAR a Grantee is to receive a portion of
such payment in shares of Common Stock, the number of shares shall be
determined by dividing such portion by the Fair Market Value of a share of
Common Stock on the exercise date. No fractional shares shall be used for such
payment and the Administrator shall determine whether cash shall be given in
lieu of such fractional shares or whether such fractional shares shall be
eliminated.
(b) Stock Awards. The Administrator may from time to time grant
restricted or unrestricted Awards of Common Stock in such amounts, on such
terms and conditions, and for such consideration, including no consideration or
such minimum consideration as may be required by law, as it shall determine.
(c) Stock Units. The Administrator may from time to time grant Awards
denominated in stock-equivalent units (stock units) in such amounts and on
such terms and conditions as it
5
shall determine. Stock units shall be credited
to a bookkeeping reserve account solely for accounting purposes and shall not
require a segregation of any of the Companys assets. An Award of stock units
may be settled in Common Stock, in cash, or in a combination of Common Stock
and cash, as determined in the sole discretion of the Administrator. Except as
otherwise provided in the applicable Grant Agreement, the Grantee shall not
have the rights of a stockholder with respect to any shares of Common Stock
represented by a stock unit solely as a result of the grant of a stock unit to
the Grantee.
(d) Performance Awards. The Administrator may, in its discretion, grant
performance awards which become payable on account of attainment of one or more
performance goals established by the Administrator. Performance awards may be
paid by the delivery of Common Stock or cash, or any combination of Common
Stock and cash, as determined in the sole discretion of the Administrator.
Performance goals established by the Administrator may be based on one or more
business criteria selected by the Administrator that apply to an individual or
group of individuals, a business unit, or the Company as a whole, over such
performance period as the Administrator may designate.
(e) Other Stock-Based Awards. The Administrator may grant other
stock-based awards may be denominated in cash, in Common Stock or other
securities, in stock-equivalent units, in stock appreciation units, in
securities or debentures convertible into Common Stock, or in any combination
of the foregoing and may be paid in Common Stock or other securities, in cash,
or in a combination of Common Stock or other securities and cash, all as
determined in the sole discretion of the Administrator.
(f) Deferral of Awards.
The Administrator (in its sole discretion) may provide that Shares or cash
that otherwise would be delivered to a Grantee as a result of the exercise of
an Option or other settlement of an Award may be converted into amounts
credited to a deferred compensation account established for such Grantee by the
Administrator as an entry on the Companys books. A deferred compensation
account established under this Section 13(f) may be credited with interest or
other forms of investment return, as determined by the Administrator. A
Grantee for whom such an account is established shall have no rights other than
those of a general creditor of the Company. Such an account shall represent an
unfunded and unsecured obligation of the Company and shall be subject to the
terms and conditions of the applicable Grant Agreement between such Participant
and the Company. The Administrator (in its sole discretion) shall establish
Grant rules, procedures and forms pertaining to any deferral of Awards pursuant
to this Section 13(f).
14. Changes in Capitalization or Control.
(a) Changes in Capitalization. Subject to any required action by the
shareholders of the Company, the number of Shares of Optioned Stock or of other
Shares subject to an outstanding Award, and the number of Shares that have been
authorized for issuance under this Plan but as to
which no Options or other Awards have then been granted (including the
number of shares automatically added to the Plan on an annual basis as provided
for in Section 3(i) and (ii)), or that
6
have been returned to this Plan upon
cancellation or expiration of an Option or an Award, as well as the price per
Share of Optioned Stock or of other Shares subject to an outstanding Award,
shall be proportionately adjusted for any change in the number of issued Shares
resulting from a stock split, reverse stock split, stock dividend, combination
or reclassification of the Common Stock, or any other change in the number of
issued Shares effected without receipt of consideration by the Company (not
counting Shares issued upon conversion of convertible securities of the Company
as effected without receipt of consideration). Such adjustment shall be made
by the Board and shall be final, binding, and conclusive. Except as expressly
provided herein, no issuance by the Company of shares of stock of any class, or
securities convertible into shares of stock of any class, shall affect, and no
consequent adjustment shall be made with respect to, the number or price of
Shares subject to this Plan.
(b) Change in Control. The Administrator may, in its discretion,
determine at any time from and after the grant of an Award the effect that a
Change in Control shall have upon the Award; provided, however, that a Change
in Control shall not have the effect of impairing the rights of any Grantee
under any then-outstanding Award without his or her prior written consent.
Without limiting the foregoing sentence, the Administrator may determine that
upon a Change in Control, an Option:
For purposes of this Section 14(b), (A) the occurrence of any of the foregoing
clauses (i), (ii), (iii) or (iv) shall not constitute an impairment of the
rights of any Optionee and (B) the Administrator shall be the Administrator
as constituted before the Change in Control occurs.
15. Amendments; Termination. The Board may at any time amend, alter,
suspend, discontinue or terminate this Plan, but no such action shall impair
the rights of any Grantee under any then-outstanding Award without his or her
prior written consent.
16. Securities Regulation Requirements.
(a) Compliance with Rule. In general, Shares shall not be issued pursuant
to the exercise of an Option or pursuant to any other Award unless the exercise
of the Option or other Award
7
and issuance of the Shares comply with all
relevant provisions of law, including, without limitation, any applicable state
securities laws, the Securities Act of 1933, as amended, the Exchange Act, the
rules and regulations promulgated thereunder, the requirements of any stock
exchange or national market system upon which the Shares may then be listed,
and the requirements of any regulatory body having jurisdiction.
(b) Optionee Investment Representation. As a condition to the exercise of
an Option, the Company may require the person exercising the Option to
represent and warrant that the Shares are being purchased only for investment
and without any present intention to sell or distribute the Shares if, in the
opinion of counsel for the Company, such a representation is required by law.
17. Written Agreements. Awards shall be evidenced by written agreements
in a form the Administrator approves from time to time. The written agreement
shall designate an Option as either an Incentive Stock Option or a Nonstatutory
Stock Option. Delay in executing a written agreement shall not affect the date
of grant of an Option; however, an Option may not be exercised until a written
agreement has been executed by the Company and the Optionee.
18. Shareholder Approval. This Plan is subject to approval by the
shareholders of the Company within 12 months after the Board initially adopts
this Plan. Shareholder approval shall be obtained in the degree and manner
required under applicable state and federal law and the rules of any stock
exchange or national market system upon which the Common Stock is listed.
19. No Employment Rights. This Plan does not confer upon any Grantee any
right with respect to continuation of employment or consulting relationship
with the Company, nor shall it interfere in any way with the Companys right to
terminate his or her employment or consulting relationship at any time, with or
without cause.
20. Term of Plan. This Plan shall become effective upon the earlier to
occur of the initial adoption by the Board or initial approval by the
shareholders of the Company, as described in Section 18. It shall continue in
effect until terminated by the Board pursuant to Section 15, except that no
ISOs shall be granted on or after the 10th anniversary of the later of (a) the
date when the Board adopted the Plan or (b) the date when the Board adopted the
most recent increase in the number of Shares available under Section 3 that was
approved by the shareholders of the Company.
21. Glossary. The following definitions apply for purposes of this Plan:
(a) Administrator means the Board or a committee appointed by the Board
under Section 4.
(b) Award means any stock option, stock appreciation right, stock award,
stock units award, performance award, or other stock-based award granted under
the Plan.
(c) Board means the Board of Directors of the Company.
(d) Change in Control means a change in ownership or control of the
Company by any of:
8
(e) Code means the Internal Revenue Code of 1986, as amended.
(f) Committee means the committee designated by the Board of Directors,
which is authorized to administer the Plan, as described in Section 4 hereof.
(g) Common Stock means the common stock of the Company.
(h) Company means Marvell Technology Group Ltd., a Bermuda corporation.
(i) Consultant means any person, other than an Employee, who is engaged
by the Company or any Parent or Subsidiary to perform consulting or advisory
services.
(j) Continuous Service means that an Optionees employment and/or
consulting relationship with the Company or a Parent or Subsidiary or service
as an Outside Director is not interrupted or terminated. Continuous Service is
not interrupted by (i) any leave of absence approved by the Company, (ii)
transfers between locations of the Company or between the
Company, a Parent, a Subsidiary, or any successor, or (iii) changes in
status from Employee to Consultant or Outside Director or from Consultant or
Outside Director to Employee
(k) Outside Director means a member of the Board who is not a common law
employee of the Company or a Parent or Subsidiary.
9
(l) Employee means any person employed by the Company or any Parent or
Subsidiary of the Company.
(m) Exchange Act means the Securities Exchange Act of 1934, as amended.
(n) Fair Market Value means, as of any date, the value of common Stock
determined as follows:
(o) Grant Agreement means a written document memorializing the terms and
conditions of an Award granted pursuant to the Plan and shall incorporate the
terms of the Plan.
(p) Grantee means the Employee, Consultant or Outside Director who
receives an Award.
(q) Incentive Stock Option or ISO means an Option intended to qualify
as an incentive stock option within the meaning of, and to the extent
otherwise permitted by, Section 422 of the Code.
(r) Nonstatutory Stock Option or NSO means an Option not intended to
qualify as an ISO.
(s) Officer means a person who is an officer of the Company within the
meaning of Section 16 of the Exchange Act and the rules and regulations
promulgated thereunder.
(t) Option means a stock option granted pursuant to this Plan.
(u) Optioned Stock means the Common Stock subject to an Option.
10
(v) Optionee means the Employee, Consultant or Outside Director who
receives an Option and includes any person who owns all or any part of an
Option, or who is entitled to exercise an Option, after the death or disability
of an Optionee.
(w) Parent means a parent corporation, present or future, as defined
in Section 424(e) of the Code.
(x) Plan means this Amended and Restated 1995 Marvell Technology Group
Ltd. Stock Option Plan.
(y) Share means a share of the Common Stock, as adjusted in accordance
with Section 14(a).
(z) Subsidiary means a subsidiary corporation, present or future, as
defined in Section 424(f) of the Code.
11
APPENDIX TO THE AMENDED AND
Table of Contents
(i) As of
May 7, 2003, 2,500,000 shares of Common Stock; and
(ii) Beginning the first business day of each calendar year starting
January 1, 2004 or after, the lesser of an additional (A) 2,000,000 shares
of Common Stock or (B) 1.5% of the outstanding shares of capital stock on
such date.
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
(As amended through May 7, 2003)
(i) such requirements as the Securities and Exchange
Commission may establish for administrators acting under plans
intended to qualify for exemption under Rule 16b-3 (or its
successor) under the Exchange Act; and
(ii) such requirements as the Internal Revenue Service may establish
for Outside Directors acting under plans intended to qualify for
exemption under Section 162(m)(4)(C) of the Code.
Table of Contents
(i) to determine the Fair Market Value of the Common Stock;
(ii) to grant Awards to such Consultants, Outside Directors
and Employees as it selects; provided, however, that
notwithstanding any other provision of the Plan, grants of Awards
to Outside Directors shall be limited to grants of Options upon
initial appointment to the Board, and such Awards shall be subject
to ratification by the Board;
(iii) to determine the terms and conditions of each Award
granted, including without limitation the number of Shares subject
to each Award, the exercise price per Share of Optioned Stock, and
whether an Option is to be granted as an ISO or a NSO;
(iv) to approve forms of agreement for use under this Plan;
(v) to determine whether and under what circumstances to
offer to buy out an Option for cash or Shares under Section 12;
(vi) to modify grants of Awards to participants who are
foreign nationals or employed outside of the United States in
order to recognize differences in local law, tax policies, or
customs; and
(vii) to construe and interpret the terms of this Plan and of
each Award granted pursuant to this Plan.
Table of Contents
(i) While the Company or a successor has outstanding any class of
equity securities required to be registered under Section 12 of the
Exchange Act, the following limitations shall apply to grants of Awards
to Employees:
(ii) No Employee shall be granted, in any fiscal year of the
Company, Awards with respect to more than 1,000,000 Shares, in the
aggregate, adjusted proportionately in connection with any change in the
Companys capitalization as described in Section 14. If an Award is
granted but canceled in the same fiscal year, it shall nonetheless count
against the foregoing limit. Reduction of an Options exercise price is
treated as a cancellation of the Option and the grant of a new Option.
(i) In the case of an ISO:
(A) granted to an Employee who, at the time of grant, owns stock
representing more than ten percent of the voting power of all classes of
stock of the Company or any Parent or Subsidiary, the per-Share exercise
price shall be at least 110% of the Fair Market Value on the date of
grant; or
(B) granted to any other Employee, the per-Share exercise price
shall be at least the Fair Market Value on the date of grant.
(ii) In the case of a NSO, the per-Share exercise price shall be at
least the Fair Market Value on the date of grant.
Table of Contents
Table of Contents
Table of Contents
Table of Contents
(i) shall become fully vested and exercisable either for a
limited period following the Change in Control or for the
remainder of the Options term;
(ii) shall terminate upon or after a specified period
following the Change in Control;
(iii) shall be cancelled in exchange for cash in the amount
of the excess of the fair market value of the Optioned Shares over
the exercise price upon termination; or
(iv) shall be treated as provided under a combination of
clauses (i) through (iii), or shall be so treated only if not
adequately assumed (or substituted for) by a surviving or
successor person or entity in the transactions or events that give
rise to the Change in Control.
Table of Contents
Table of Contents
(i) a merger or consolidation in which the holders of stock
possessing a majority of the voting power in the surviving entity
(or a parent of the surviving entity) did not own a majority of
the Common Stock immediately before the transaction;
(ii) the sale of all or substantially all of the Companys
assets to any other person or entity (other than a Subsidiary);
(iii) the liquidation or dissolution of the Company;
(iv) the direct or indirect acquisition by any person or
related group of persons of beneficial ownership (within the
meaning of Rule 13d-3 of the Exchange Act) of securities
possessing more than 50% of the total combined voting power of the
Companys outstanding securities pursuant to a tender or exchange
offer made directly to the Companys shareholders that the Board
does not recommend that the shareholders accept, or
(v) a change in composition of the Board over a period of 36
consecutive months such that a majority of the Board ceases, by
reason of one or more contested elections for Board membership, to
be composed of individuals who either (A) have been Board members
continuously since the beginning of that period or (B) have been
elected or nominated for election as Board members during that
period by at least a majority of the Board members described in
clause (A) who were in office when the Board approved the election
or nomination.
Table of Contents
(i) If the Common Stock is quoted on an established stock
exchange or national market system, including without limitation
the National Association of Securities Dealers, Inc. Automated
Quotation (NASDAQ) National Market System, Fair Market Value
shall be the closing sales price (or the closing bid, if no sales
are reported) as quoted on that exchange or system for the day of
the determination, as reported in The Wall Street Journal or an
equivalent source, or if the determination date is not a trading
day, then on the most recent preceding trading day;
(ii) If the Common Stock is quoted on NASDAQ (but not on the
National Market System) or regularly quoted by a recognized
securities dealer but selling prices are not reported, Fair Market
Value shall be the mean between the high bid and low asked prices
for the Common Stock on the day of the determination, or on the
most recent preceding trading day if the determination date is not
a trading day; or
(iii) In the absence of an established market for the Common
Stock, Fair Market Value shall be determined by the Administrator.
Table of Contents
Table of Contents
RESTATED 1995 STOCK OPTION PLAN
Of MARVELL TECHNOLOGY GROUP LTD.
IN RESPECT OF ISRAELI EMPLOYEES
1.
Purpose
The purpose of this appendix is to modify, to the extent set forth
herein, the Amended and Restated 1995 Marvell Technology Group Ltd. Stock
Option Plan (the Plan) in respect of the Israeli employees of Marvell
Technology Group Ltd. and its affiliates and subsidiaries who are
eligible to participate in the Plan in accordance with its terms, in
order to reflect the specific requirements of the Israeli law.
2.
Defined Terms
(a)
Capitalized terms used but not defined herein shall have the
meanings provided in Section 21 of the Plan.
(b)
In addition, in this Appendix, the following terms shall have
the meanings set forth beside them:
102 Provisions | The provisions of section 102 of the Ordinance and of the Income Tax Rules (Tax Relief in Allocating Shares to Employees), 5749-1989, as they shall apply from time to time on shares and options issued hereunder, including the Special Conditions; | |
Effective Date | The latest of the date the Options were issued or the date of the Income Tax Commissioner approval that the Plan satisfies the Special Conditions; | |
Employer | The Company, any of its Subsidiaries or its Parent employing Israeli Employees; | |
Israeli Employees | Employees subject to taxation in Israel; | |
Trustee | Galileo Technology Ltd., or in the alternate, the Trust Company of Investek Bank, or any other trustee who shall replace same by the Board for the purposes of this Plan; | |
Ordinance | The Income Tax Ordinance (New Version), 5721-1961; | |
Special Conditions | Special conditions set by the Israeli Income Tax Commissioner in connection with the issuance of the Options hereunder, by the power vested in him/her under section 102 of the Ordinance, if |
12
and to the extent the Commissioner shall so set; | ||
Tax Lockup Period | Two years following the Effective Date or such other period of time in accordance with the 102 Provisions, as they shall be amended from time to time. |
(c) | The Israeli Employees shall be entitled to exercise their options in accordance with the terms of the Plan, subject to the terms of this Appendix. In the event of any contradiction between any term of this Appendix and any term of the Plan, the provisions of this Appendix shall override with respect to the Israeli Employees, in respect of whom this Appendix shall constitute an integral part of the Plan and references to the Plan in respect of the Israeli Employees shall be interpreted accordingly. |
3. | Special Conditions |
(a) | The Company shall apply to the Income Tax Commissioner to approve the Trustee and the Plan under the 102 Provisions. Subject to the approval of this Plan by the Israeli Income Tax Commissioner, the Special Conditions shall apply to the plan and to this Appendix. | ||
(b) | The Administrator shall exercise its discretion under the Plan in accordance with the terms of this Appendix. |
4. | Eligibility | |
Options shall not be granted to any Israeli Employee who is, or on giving effect to such grant, will become, the holder of a controlling interest (baal shlita) in the Company, as defined in section 32(9) of the Ordinance. | ||
5. | Trust |
(a) | The Options and the Shares shall be issued directly in the name of the Trustee and shall be held in escrow by the Trustee for the Israeli Employees benefit, for no less then the Tax Lockup Period, all according to the terms of this Appendix. | ||
(b) | In the event that bonus shares shall be issued on account of the Shares, such bonus shares shall be issued by the Company to the Trustee. The 102 Provisions shall apply to such bonus shares for all purposes. | ||
(c) | The Trustee shall be entitled to set additional exercise procedures to those described in the Plan, as the Trustee shall see fit, provided that the Trustee has given the Company prior written notice of any such procedures. |
13
6. | Taxes |
(a) | The Israeli Employees shall be taxed in respect of the Options in accordance with the provisions of the Ordinance, including the 102 Provisions. The Israeli Employee will not be entitled to the exemption from tax contained in sections 95 or 97(a) of the Ordinance. | ||
(b) | Without derogating from section 9(g) of the Plan, any tax imposed in respect of the Options and/or the Shares and/or the sale and/or the transfer of the Options and/or the Shares shall be borne solely by the Israeli Employee, and in the event of the death of the Israeli Employee, by the Israeli Employees heirs or successors. The Employer, shall not bear the aforementioned taxes, directly or indirectly, nor shall the Employer be required to gross such tax up in the Israeli Employees salaries or remuneration. The imposed tax shall be paid by the Israeli Employee or deducted, on the date such tax is payable, from the sale consideration paid to the Trustee by the Israeli Employee, as applicable. | ||
(c) | At the end of the Tax Lockup Period, the Israeli Employee (or the Israeli Employees heirs or successors) shall be entitled at any time to instruct the Trustee to transfer the Options or the Shares to which such Israeli Employee is entitled to the Israeli Employee or its nominees, or, if appropriate, to sell the Shares and pay the consideration received to the Israeli Employee. | ||
Subject to the 102 Provisions, the Trustee shall not transfer the Options and/or the Shares to the Israeli Employees name, and shall not transfer the consideration received from the sale of the Shares to the Israeli Employee, unless one of the following conditions shall be fulfilled: |
(i) | The Israeli Employee has provided the Trustee with certification from the assessing officer that the tax has been paid; or | ||
(ii) | The Israeli Employee has paid the Trustee an amount equal to 30% of the consideration, as defined in section 102 of the Ordinance (the Taxable Consideration) for such sale, and the Trustee has reviewed the manner of calculating the payable amount and is fully satisfied that the calculation was performed lawfully; or | ||
(iii) | The Trustee has deducted an amount equal to 30% of the Taxable Consideration from the consideration received from the sale of the Shares. |
(d) | The effects of any future amendment to the tax arrangements which apply to the issuance of securities to the Israeli Employees, shall apply to the Israeli Employees in accordance with such provisions of law, and the Israeli Employees shall bear the full cost thereof, unless the modified arrangement expressly provides otherwise. |
14
(e) | Each Israeli Employee shall indemnify the Employer and/or the Trustee, immediately upon receipt of notice from the Employer and/or the Trustee, for any amount (including interest and/or fines of any type and/or linkage differentials in respect of tax and/or withheld tax) payable by such Israeli Employee under law (including under the 102 Provisions), and which has been paid by the Employer or the Trustee or which the Employer or the Trustee are required to pay by the tax authorities. | ||
(f) | Should the Israeli Amendment of Tax Law Bill 2000 (or any other substantially similar draft legislation) (the New Law) enter into effect, the Board shall be entitled, at its absolute discretion, to order the Trustee to make an application to the Israeli Tax Commission in order to request that the provisions set out in the New Law, which replace the 102 Provisions, shall apply to the Israeli Employees, regarding either existing or future allotments, as shall be determined in the New Law. |
7. | Miscellaneous |
(a) | The Israeli Employees shall sign any document required by the Trustee or the Income Tax Commission to give effect to the provisions of this Appendix. | ||
(b) | Without derogating section 19 of the Plan, it is hereby acknowledged that the Options and/or the Exercise Shares are extraordinary, one-off benefits granted to the Offerees, and are not and shall not be deemed a salary component for any purpose whatsoever, including in connection with calculating severance compensation under the Severance Pay Law, 5723-1963 and the regulations promulgated thereunder. | ||
(c) | The grant of Options to each Israeli Employee shall be made in consideration of a waiver on the part of such Israeli Employee of a portion of the Israeli Employees salary in the amount of NIS 1. | ||
(d) | In the event of a change in control of the Company is proposed during the Tax Lock Up Period, the consummation which will cause the breach of the terms of the 102 Provisions, the Company will use its best efforts to apply to the Israeli Tax Authorities to obtain a pre-ruling to regulate the tax treatment applicable to the Options in the context of the proposed transaction. | ||
(e) | Except as expressly provided in this Appendix, the provisions of this Appendix do not supercede any provisions of the Plan, and the provisions of the Plan shall govern all Options granted to Israeli Employees. |
15
Marvell Semiconductor, Inc.
In order for your shares to be voted by the Proxies, your proxy card must be received by 2:00 p.m., local time, on June 27, 2003 at the address set forth on the reverse hereof. Regardless of the number of shares you own or whether you plan to attend the meeting, it is important that your shares be represented and voted. Please complete, sign, date and return this proxy card. Returning this proxy card does NOT deprive you of your right to attend the Annual General Meeting and to vote your shares in person.
* FOLD AND DETACH HERE *
Marvell Technology Group Ltd.
PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned, a shareholder of MARVELL TECHNOLOGY GROUP LTD., a Bermuda corporation (the Company), acknowledges receipt of a copy of the Companys Notice of Annual General Meeting of Shareholders and the accompanying Proxy Statement and the Companys Annual Report on Form 10-K for the year ended February 1, 2003; and, revoking any proxy previously given, hereby constitutes and appoints Sehat Sutardja and George Hervey, and each of them, his, her or its true and lawful agents and Proxies with full power of substitution in each, to vote the shares of common stock of the Company standing in the name of the undersigned at the Companys Annual General Meeting of Shareholders to be held on Friday, June 27, 2003 at 3:00 p.m., local time, and at any adjournment or postponement thereof, and instructs said Proxies to vote as follows:
Shares represented by this proxy will be voted as directed by the shareholder. If no such directions are indicated, the Proxies will have the authority to vote FOR the election of directors, FOR proposals 2, 3 and 4 and in accordance with the discretion of the Proxies on any other matters as may properly come before the Annual General Meeting.
Please complete, sign, date and return the proxy card promptly using the enclosed envelope.
YOUR VOTE IS VERY IMPORTANT.
SEE REVERSE SIDE |
||
Dear Marvell Shareholder:
Your vote is important. Please consider the proposals discussed in the enclosed Proxy Statement of Marvell Technology Group Ltd. (the Company) and cast your vote by:
| Completing, dating, signing and mailing the proxy card in the enclosed postage-paid envelope; or | |
| Sending the proxy card, if the envelope is missing, to: |
Marvell Technology Group Ltd. | |
c/o Wachovia Bank | |
Attn: Proxy Tabulation NC-1153 | |
P.O. Box 217950 | |
Charlotte, NC 28254-3555 |
If you receive more than one set of proxy materials from the Company, please act promptly on each set you receive because each set represents separate shares. If you return multiple cards, you may use the same return envelope. Please indicate if you plan to attend the meeting in the box provided. If you wish to revoke your proxy you may do so at any time before your proxy is voted at the Annual General Meeting. You can do this in one of three ways:
(1) | you can send a written notice stating that you want to revoke your proxy; | |
(2) | you can complete and submit a new proxy card; or | |
(3) | you can attend the Annual General Meeting and vote in person. |
You must submit your notice of revocation or a new proxy card to the Company at the address set forth above. Your notice of revocation or new proxy card must be received by 2:00 p.m. local time on June 27, 2003 or at the Annual General Meeting.
. FOLD AND DETACH HERE .
x Please mark your votes as in this example.
Unless otherwise specified, this proxy will be voted FOR each of the nominees for director and each proposal listed | ||||||
below. | ||||||
1. To elect three directors as the Class 3 Directors each to hold office for a three-year term or until his or her successor is duly elected and qualified. |
Nominees: 1. Dr. Sehat Sutardja, Ph.D. 2. Weili Dai 3. Dr. Pantas Sutardja, Ph.D. |
3. To approve an amendment to the
Companys 2000 Employee Stock Purchase Plan. o FOR o AGAINST o ABSTAIN |
||||
FOR all Nominees listed (except as marked to the contrary above) o |
WITHHOLD authority to vote for all nominees o |
4. To approve the Companys Amended and
Restated 1995 Stock Option Plan. o FOR o AGAINST o ABSTAIN |
||||
To withhold authority to vote for any nominee(s), strike a line through the name(s) of such nominee(s) in the above list. | 5. In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof. | |||||
2. To Re-appoint PricewaterhouseCoopers LLP
as the independent auditors of the Company for the 2004 fiscal
year ending January 31, 2004 and to authorize the Board of
Directors to fix the auditors remuneration. o FOR o AGAINST o ABSTAIN |
||||||
o I plan on attending the meeting. |
This proxy must be signed exactly as the shareholder name appears hereon. In the case of joint ownership, any owner may sign but the vote of a senior shareholder who tenders a vote, in person or by proxy, will be accepted to the exclusion of the other owners. Seniority is determined by the order in which the name stands in the Register of Shareholders. Executors, administrators, trustees, etc., should give their full title, as such. If the shareholder is a corporation, a duly authorized officer should sign on behalf of the corporation and should indicate his or her title.
SIGNATURE(S) | DATE |